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Chapter 1 
 
INTRODUCTION 
 
The central dogma of molecular biology tells us that RNA serves as a faithful 
copy of its DNA template (Fig.1). Yet, RNA is frequently modified by two cellular 
mechanisms, alternative-splicing and RNA editing, which change its genomically-
encoded sequence. This is in addition to traditional splicing, which removes genomically 
“marked” introns from precursor messenger RNA (pre-mRNA) to form the open reading 
frame (ORF) in many mRNAs. Alternative-splicing alters a transcript’s canonical 
exon/intron splicing pattern by using alternative splice sites to lengthen, shorten, 
introduce or remove exons. RNA editing can delete, insert, or chemically change bases 
in a transcript through the action of specific enzymes. By altering the sequence of an 
mRNA, RNA editing and alternative splicing events can change the encoded protein’s 
amino acid sequence and manipulate its function. The creation of multiple protein 
isoforms from a single RNA transcript is a powerful mechanism to enhances a 
genome’s output, and also dramatically increases the complexity with which RNA and 
proteins are regulated. 
 
History Of RNA Editing 
Insertion/deletion editing 
RNA editing encompasses any mechanism for enzymatically altering individual 
nucleotides within an RNA transcript. The initial discovery of an RNA editing event was 
made in trypanosome mitochondrial mRNA encoding the respiratory chain protein 
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Figure 1. Central dogma of molecular biology. DNA is transcribed into mRNA, 
which is translated into protein. RNA serves as a copy of its DNA template, but 
RNA modification greatly enhances genomic output. (Illustration used with  the 
permission of Dr. Ronald Emeson) 
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cytochrome c oxidase subunit II (coxII) (Benne et al., 1986). In trypanosomes, the coxII 
gene contains a frameshift which is corrected by the addition of four uridines in the coxII 
transcript, allowing functional expression of the CoxII protein (Benne et al., 1986). 
Subsequently, it was discovered that the related cytochrome c oxidase subunit III 
(coxIII) gene undergoes extensive uridine insertion and deletion which provides more 
than 50 percent of the coxIII reading frame (Feagin et al., 1988). We now know 
kinetoplastid mitochondrial RNA (kRNA) (found in flagellated protozoa from 
Trypanosoma and Leishmania and other species) is characterized by a prevalent 
uridine insertion/deletion mechanism which creates start and stop codons, corrects 
internal frameshifts, and provides substantial portions of coding regions by insertion of 
large numbers of uridines (“panediting”) that together unlock the kinetoplastid 
mitochondrial proteome (Aphasizhev and Aphasizheva, 2014; Lukes et al., 2005). While 
U-insertion/deletion is the primary form of RNA editing in kinetoplastids, the coding 
region of trypanosome transfer RNA (tRNA) undergoes infrequent adenosine-to-
guanosine (A-to-G) and adenosine-to-uridine (A-to-U) editing (Rubio et al., 2013).  
 
Editing by base-conversion 
A different scenario is observed in mammals, where RNA editing occurs by base 
conversion rather than an insertion/deletion mechanism. RNA editing in mammals 
consists predominately of adenosine-to-inosine (A-to-I) editing and, to a lesser extent, 
cytidine-to-uridine (C-to-U) editing. Although not as common, C-to-U editing was 
discovered first: a single posttranscriptional C-to-U change was identified in rabbit and 
human apolipoprotein B mRNA shortly after the discovery of RNA editing in 
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trypanosomes (Chen et al., 1987; Powell et al., 1987).  Apolipoprotein B-100 (apoB-
100) and apolipoprotein B-48 (apoB-48) make up the B class of water-insoluble 
lipoproteins. ApoB-100 is a serum protein involved in the appropriate transport of 
cholesterol; ApoB-48 is essential for fat absorption in the small intestine and is identical 
to the N-terminal portion of apoB-100 (Chan et al., 1997; Hardman et al., 1987). The 
important role of these proteins in fat metabolism has heralded much research interest, 
but initially scientists could only identify the gene encoding apoB-100. Eventually, 
sequence analysis of apoB-100 cDNA clones from rabbit and human small intestine 
revealed a non-genomically encoded C-to-U conversion which changes a mid-coding 
region CAA (glutamine) codon to a UAA (stop) codon (Chen et al., 1987; Powell et al., 
1987). Translation of the edited apoB-100 mRNA results in a carboxy (C)-terminal 
truncation and expression of apoB-48 (Hardman et al., 1987). Thus, both apoB proteins 
are encoded by a single gene and their differential expression depends on RNA editing. 
ApoB mRNA editing is the prototypical C-to-U editing event, and its importance is 
underscored by the dysregulation of plasma cholesterol and triglyceride levels in 
APOBEC1 knockout (-/-) mice, which lack the cytidine deaminase (APOBEC1) 
responsible for the editing activity (Nakamuta et al., 1996).  
Recent advances in high-throughput sequencing technology have permitted 
identification of additional posttranscriptional C-to-U changes across entire 
transcriptomes. As a result, C-to-U editing has been identified in tens of additional 
transcripts in both liver and small intestine. Interestingly, these editing events occur 
almost exclusively in the 3’ untranslated region (UTR) of mRNAs, with no additional 
editing events identified in coding regions (Blanc et al., 2014; Rosenberg et al., 2011).  
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C-to-U editing also occurs in the organelles (plastids and mitochondria) of plants, 
ranging from a few editing events to thousands depending on the species (Graves et al., 
1990; Takenaka et al., 2014; Takenaka et al., 2013). C-to-U events are observed across 
all land plants, including flowering plants, mosses, and ferns (Begu et al., 2011; 
Castandet and Araya, 2011; Sper-Whitis et al., 1996; Takenaka et al., 2014; Takenaka 
et al., 2013; Tasaki and Sugita, 2010).  The mechanistic and functional intricacies of 
editing in plants are still being explored, but it is known that C-to-U editing in plants 
involves an extensive protein family bearing pentatricopeptide (PPR) repeat domains 
that recognize specific sequences 5’ to the editing site  (Kotera et al., 2005; Okuda et 
al., 2007; Takenaka et al., 2014; Takenaka et al., 2013). In contrast to mammals, C-to-U 
editing in plants seems to occur largely within coding regions where it restores highly 
conserved amino acids that have been “lost” by divergent sequences in the genetic 
material. Interestingly, although the editing mechanism is different (see previous 
discussion of “U insertion/deletion editing”), plants, like trypanosomes, rely on editing of 
mRNAs encoding mitochondrial protein subunits (coxI-III) to restore functional protein 
expression (Begu et al., 2011; Gualberto et al., 1990; Saiardi and Quagliariello, 1992; 
Sper-Whitis et al., 1996).  A handful of newly identified mammalian PPR proteins have 
been implicated in mitochondrial RNA processing, although whether their job includes 
C-to-U editing is still unknown (Lightowlers and Chrzanowska-Lightowlers, 2008; 
Rackham and Filipovska, 2012). Disruption of at least one of these proteins appears to 
have serious consequences both in mouse and human (Ruzzenente et al., 2012; Xu et 
al., 2008; Xu et al., 2012).  
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A-to-I editing activity was first encountered in yeast tRNA where adenosine in the 
anti-codon is converted to inosine (Holley et al., 1965). Twenty years later, A-to-I activity 
in double-stranded RNA (dsRNA) was discovered serendipitously in Xenopus laevis 
eggs. Unsuccessful attempts at using an antisense RNA approach to gene knockdown 
led researchers to observe what appeared to be an “unwinding activity” (Rebagliati and 
Melton, 1987). Further studies revealed that the targeted RNA was undergoing 
modification, specifically the deamination of adenosine moieties to inosine. The 
“unwinding” was actually A-to-I “hyperediting” that disrupted the hybrid RNA duplex 
structure formed by the complementary RNAs (Bass and Weintraub, 1988; Wagner et 
al., 1989; Wagner et al., 1990). 
Like C-to-U editing, A-to-I editing occurs by enzymatic base conversion (Fig. 2A). 
A-to-I editing is the most prominent type of editing in both vertebrates and invertebrates, 
from Drosophila to humans. Akin to C-to-U editing of apoB mRNA, A-to-I editing 
introduces specific essential amino acid residues that are not encoded by genomic 
DNA. A-to-I editing has attracted the attention of researchers for its critical role in proper 
neuronal functioning. The remainder of this thesis will explore this role more fully; 
examining how A-to-I editing sustains organismal viability by modulation of RNA. I will 
also focus on the activities of ADAR1, a unique A-to-I editor with a special role. 
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ADARs and A-to-I Editing 
 
Overview 
A-to-I editing of precursor and mature mRNAs and primary miRNA transcripts is 
mediated by a family of double-stranded RNA-specific adenosine deaminases (ADARs) 
that catalyze the hydrolytic deamination of the C-6 position within the purine ring 
(Polson et al., 1991) and have been the topic of numerous reviews (Bass, 2002; Hogg 
et al., 2011; Nishikura, 2010).	  In mammals, three ADAR proteins (ADAR1, ADAR2 and 
ADAR3) have been purified and their corresponding genes have been identified (Chen 
et al., 2000; Hough and Bass, 1994; Kim et al., 1994; Liu et al., 1997; O'Connell et al., 
1995). ADAR1 and ADAR2 are expressed in almost all cell types examined (Melcher et 
al., 1996; Wagner et al., 1990) and convert A-to-I in extended regions of duplex RNA 
within pre-mRNAs, mRNAs, primary miRNA transcripts and viral RNAs (Berg et al., 
2001; Luciano et al., 2004; Schaub and Keller, 2002; Yang et al., 2006). The expression 
of ADAR3 has been detected only in post-mitotic neurons in brain regions such as the 
amygdala and thalamus (Chen et al., 2000), yet ADAR3 has not demonstrated any 
catalytic activity using synthetic dsRNA or known ADAR substrates (Chen et al., 2000; 
Maas et al., 2003). ADAR1 and ADAR2 have overlapping yet distinct patterns of editing 
with some sites edited by only one enzyme and other sites edited equally well by both 
(Bass, 2002; Hogg et al., 2011; Nishikura, 2010).  
 A-to-I editing involves a slight twist; inosine is an unnatural base with different 
binding properties than adenosine, instead more closely resembling guanosine. As a  
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consequence, inosine base-pairs with cytosine instead of uridine, and for this reason A-
to-I editing is functionally equivalent to an A-to-G change (Fig. 2B). The full impact of an 
mRNA editing event is realized during translation, when a codon-specific A-to-I change 
alters the identity of the encoded amino acid because translational machinery 
recognizes inosine as guanosine. In addition to specific amino-acid changes, A-to-I 
editing can create new splice acceptor sites in order to regulate pre-mRNA splicing 
patterns, although this has been observed infrequently (Feng et al., 2006; Rueter et al., 
1999). miRNAs are also affected by A-to-I editing, which changes their target specificity 
and subsequently plays a role in regulating gene expression (Blow et al., 2006; 
Kawahara et al., 2007).  
 
 Sections entitled ADAR1 and ADAR2 of the following text were previously 
published in Current Topics in Microbiology and Immunology in July 2011 (Hood and 
Emeson, 2012). Reprinted with permission of Elsevier. 
 
ADAR1 
The ADAR1 gene encodes two major protein isoforms, a 150 kilodalton (kDa) protein 
(p150) and a constitutively expressed, N-terminally truncated 110 kDa protein (p110), 
encoded by transcripts with alternative exon 1 structures that initiate from different 
promoters (George and Samuel, 1999b) (Fig 3A). The predicted protein sequence of 
ADAR1 indicates that it contains three copies of a dsRNA-binding motif (dsRBM), a 
motif shared among numerous dsRNA-binding proteins  
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Figure 2. A-to-I conversion and inosine-cytosine base-pairing. A) Adenosine is 
converted to inosine by hydrolytic deamination. The amine group is replaced by oxygen. 
B) Inosine is chemically similar to guanosine and preferentially base-pairs with cytosine.  
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Figure 3. Generation of multiple mouse ADAR1 isoforms by alternative splicing. 
A) A schematic representation of the mouse ADAR1 gene is shown, indicating the 
presence of alternative exon 1 sequences that can generate multiple mRNA isoforms 
by alternative splicing to encode distinct p110 and p150 proteins, respectively; kb, 
kilobase. An alternative splicing event in exon 7 leads to additional ADAR1 RNA and 
protein diversity, generating RNA isoforms (7a and 7b) encoding proteins differing in 
size by 26 amino acids. B) The major mouse ADAR1 protein isoforms are presented, 
indicating their relative size in amino acids, as well as the location of the putative NLS 
and NES signals, Z-DNA binding domains (Zα and Zβ), dsRBMs, and the catalytic 
adenosine deaminase domain (Reprinted from (Hood et al., 2014) with permission). 
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A) B) 
B-DNA Z-DNA 
Figure 4. An editing duplex and the orientation of Z-DNA. A) dsRNA substrate 
demonstrating exonic/intronic duplex secondary structure, A-C and G-G mismatches, and a 
loop. Exonic portion shown in purple. Editing site is circled. (Illustration used with permission 
of Dr. Ronald Emeson). B) Representation of Z-DNA and B-DNA; left and right-handed 
conformations, respectively.  
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(Burd and Dreyfuss, 1994; Fierro-Monti and Mathews, 2000), a nuclear localization 
signal (NLS) in the third dsRBM (Eckmann et al., 2001), and a region homologous to the 
catalytic domain of other known adenosine and cytidine deaminases (Fig. 3B). The 
amino-terminus of the p150 isoform also contains two Z-DNA binding domains, the first 
of which (Zα) overlaps with a  
leucine-rich nuclear export signal (Fig 3B) (Poulsen et al., 2001). The Z-DNA binding 
domains have been proposed to tether ADAR1 to sites of transcription (Herbert and 
Rich, 1996) or to mediate interactions between ADARs and other proteins (Poulsen et 
al., 2001). The locations of the nuclear localization and nuclear export sequences in 
ADAR1 are consistent with observations that the p150 isoform shuttles between the 
cytoplasm and the nucleus, whereas the p110 protein is localized predominantly to the 
nucleus (Eckmann et al., 2001; Fritz et al., 2009; Patterson and Samuel, 1995; 
Strehblow et al., 2002). 
Alternative splicing within exon 7 of ADAR1 generates two distinct mRNA 
isoforms that differ by 26 amino acids that encode the linker region between the third 
double-stranded RNA binding motif and the catalytic domain to affect site-selective 
editing efficiency (Fig. 3A) (Liu et al., 1997; Liu and Samuel, 1999) (Fig. 3A). Total 
ablation of ADAR1 expression in mice results in embryonic lethality at day 11.5, manifested 
by liver disintegration (Hartner et al., 2004) and widespread apoptosis (Wang et al., 2004), 
suggesting that ADAR1 may promote survival of numerous tissues by editing dsRNAs 
required for protection against programmed cell death. Similar embryonic lethality also 
results from selective loss of the p150 isoform, indicating a critical role for this ADAR1 
isoform in embryonic development (Ward et al., 2011). Heterozygosity for an ADAR1 loss-
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of-function allele can result in dyschromatosis symmetrica hereditaria (DSH), a genetic 
disorder characterized by pea-sized hyperpigmented and hypopigmented macules on the 
hands and feet (Gao et al., 2005; Miyamura et al., 2003; Suzuki et al., 2005), whereas no 
such phenotype is observed in mice that are heterozygous for an ADAR1-null allele 
(Hartner et al., 2004; Wang et al., 2004). 
ADAR2 
ADAR2 is an 80 kDa protein with structural features similar to those observed for ADAR1 
(Melcher et al., 1996). ADAR2 contains an NLS and two dsRBMS, sharing approximately 
25% amino acid sequence similarity with the dsRBMs of ADAR1. ADAR2 also contains an 
adenosine deaminase domain sharing 70% amino acid similarity with ADAR1, as well as 
three zinc-chelating residues conserved in the deaminase domain of both enzymes. As with 
ADAR1, multiple cDNA isoforms of ADAR2 have been identified in rats, mice, and humans 
including alternative splicing events in mRNA regions encoding the deaminase domain and 
near the amino terminus (Gerber et al., 1997; Lai et al., 1997; Maas and Gommans, 2009b; 
Rueter et al., 1999). Of particular interest is an alternative splicing event that introduces an 
additional 47 nucleotides near the 5'-end of the ADAR2 coding region, resulting in a 
frameshift that is predicted to produce a 9 kDa protein lacking the dsRBMs and catalytic 
deaminase domain required for protein function (Rueter et al., 1999). This alternative 
splicing event is dependent upon the ability of ADAR2 to edit its own pre-mRNA, converting 
an intronic adenosine-adenosine (AA) to an adenosine-inosine (AI) dinucleotide that 
effectively mimics the highly conserved AG sequence normally found at 3'-splice junctions. 
These observations indicate that RNA editing may serve as a mechanism for the regulation 
of alternative splicing and provides an autoregulatory strategy by which ADAR2 can 
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modulate its own level of expression (Feng et al., 2006; Rueter et al., 1999). Ablation of 
ADAR2 expression in mutant mice results in death between postnatal day 0 (P0) and P20, 
as mutant animals become progressively seizure-prone after P12 (Higuchi et al., 2000). 
 
 
ADAR3  
ADAR3 is the third member of the ADAR family, but is catalytically inactive despite 
similar domain structures (Chen et al., 2000). In vitro, ADAR3 does not demonstrate 
editing activity with any known substrates (Chen et al., 2000). This could be due to an 
inability to form homodimers, as it was shown that ADAR3 remains monomeric (Cho et 
al., 2003). However, additional evidence suggests that endogenous ADAR3 is 
homodimeric, and thereofore could potentially edit endogenous substrates (Cho et al., 
2003). In contrast to ADAR1 and ADAR2, ADAR3 expression is limited to the brain. An 
arginine-rich region in the N-terminus of ADAR3 interacts with the import protein KPNA2 
and controls ADAR3 localization (Maas and Gommans, 2009a). High levels of ADAR3 
have been observed in pediatric tumors (Cenci et al., 2008).  
 
Substrate requirements and specificity 
A-to-I editing requires a dsRNA substrate. In mRNAs, the necessary duplex 
structure is typically formed from exonic sequence containing the editing site and an 
intronic editing site complementary sequence (ECS) (Higuchi et al., 1993; Maas et al., 
1996) (Fig. 4B). miRNAs and some viral genomes are also sources of cellular dsRNA. 
ADAR enzymes exclusively bind dsRNA, mediated by double-stranded RNA binding 
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motifs (dsRBMs) that recognize structural elements within a duplex such as bulges, 
loops, and mismatches in combination with some sequence specificity (Fig. 4B) 
(Eggington et al., 2011; Kallman et al., 2003; Kuttan and Bass, 2012; Lehmann and 
Bass, 1999; Masliah et al., 2013; Nishikura et al., 1991; Polson and Bass, 1994). The 
imperfect character of the dsRNA directs site-specific editing of adenosines. In contrast, 
with a perfect duplex, approximately fifty-percent of the available adenosines can 
undergo indiscriminate editing before the duplex structure is disrupted, preventing 
further deamination (Bass and Weintraub, 1988; Cattaneo, 1994; Nishikura et al., 1991). 
Editing can occur in dsRNA duplexes as small as 15 base-pairs (bp), although the most 
efficient editing occurs in duplexes larger than 100 bp (Nishikura et al., 1991). This 
diminutive size requirement is inclusive of a wide range of editing targets; for example, 
miRNAs are typically only 22 nucleotides (nt) in length 
 
Protein structure  
All three ADAR enzymes share a similar set of functional domains, including two 
or three dsRBMs, a catalytic domain, and signaling motifs including a NLS and NES. In 
addition, ADAR1 contains a Z-DNA binding motif (Figs. 2B, 3A). The protein and 
domain sequences of ADAR1 and ADAR2 homologs are conserved among mouse, rat, 
human and Drosophila and C. elegans (Keegan et al., 2011; Rosenthal and Seeburg, 
2012; Tonkin et al., 2002).  
Double-stranded RNA binding motifs 
Conserved ~70 a.a. dsRBMs are common to all ADAR enzymes, enabling 
catalytic activity by recognizing and binding dsRNA substrates (Carlson et al., 2003) 
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(Saunders and Barber, 2003). dsRBMs can bind both perfect duplexes and a variety of 
imperfect editing substrates, and these domains work together to bring an editing site 
into proximity with the catalytic domain (Stefl et al., 2006). Substrate recognition by the 
dsRBMs is enhanced by loops, bulges and mismatches, particularly A to C mismatches 
(Fig. 4B) (Stefl et al., 2006).  Mutation of the individual dsRBMs can abolish editing, but 
the importance of any given dsRBM seems to be substrate dependent (Palavicini et al., 
2009; Xu et al., 2006).  Although dsRBMs are thought to primarily recognize secondary 
structure, the solved protein structure of an ADAR2 dsRBM bound to a site-specific 
dsRNA substrate shows that the dsRBM in fact recognizes and interacts with specific 
bases in the RNA (Stefl et al., 2010). Mutational analysis of either the specific 
nucleotides or the amino acids involved in the interaction can attenuate or abolish 
editing (Stefl et al., 2010). 
Catalytic domain 
In the presence of catalytic activity and water, adenosine deamination occurs on 
the C6 carbon of adenine (Fig. 2A)(Polson et al., 1991). Oxygen from a water molecule 
replaces the amine group and the resulting nucleotide is inosine (Fig. 2A). Each ADAR 
enzyme has a deaminase domain located at the C-terminus that is responsible for 
catalytic activity. However, as mentioned previously, ADAR3 demonstrates no catalytic 
activity with any known editing substrate, although the reason for this is not evident 
(Chen et al., 2000). Much of the work done regarding the chemistry of an A-to-I editing 
reaction has been performed with ADAR2, although the same residues appear to be 
involved in ADAR1 catalysis (Goodman, 2012 #80}. Once an ADAR is bound to a 
dsRNA containing an editing site, the adenosine is ‘flipped out’ from the surrounding 
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bases stacked in the helix, allowing it to enter the active site (Goodman et al., 2012). 
Conserved cysteine and histidine residues bind a zinc ion that in turn stabilizes a bound 
water molecule.  An essential glutamate (E) residue (E396 and E912 in ADAR2 and 
ADAR1, respectively) is thought to deprotonate the water molecule, leaving a reactive 
hydroxide ion to attack the adenine base, leading to loss of the amine group and 
subsequent oxidation (Goodman et al., 2012).  
Z-DNA binding domains 
ADAR1 is unique amongst other ADAR family members with regard to its N-
terminal Z-DNA binding motif consisting of two subdomains (Zα and Zβ) connected by a 
linker region (Fig. 3B) (Liu et al., 1998; Schade et al., 1999). The role of Z-DNA binding 
domains in ADAR1 function is poorly understood, but ongoing studies continue to 
provide increased clarity.  
Initial experiments showed that ADAR1 binds with high affinity to Z-DNA (Herbert 
et al., 1997; Herbert et al., 1995a, b). Z-DNA is the non-canonical, left-handed 
conformation of DNA (Fig. 4B)(Choi and Majima, 2011; Wang and Vasquez, 2007) DNA 
exists primarily as B-DNA, the familiar right-handed conformation first described by 
Watson and Crick (Fig. 4B). Z-DNA is formed in the wake of polymerase activity, and it 
has been postulated that this may help localize ADAR1 to areas of active transcription 
(Wang and Vasquez, 2007) (Brown and Rich, 2001). ADAR1 can also convert DNA to 
the Z-form; ADAR1 binds via Zα to a sequence containing CG-repeats (preferred) on 
one strand of B-DNA, a second ADAR1 monomer then binds the alternate strand and 
stabilizes the Z-conformation (Kang et al., 2009).  Zα is primarily responsible for binding 
 18 
to Z-DNA, but it appears Zβ may enhance the activity of Zα or change the editing 
pattern of bound ADAR1 (Athanasiadis et al., 2005). 
Signaling motifs and cellular localization  
ADAR1 and ADAR2 contain a NLS within the third dsRBM and N-terminus, 
respectively (Eckmann et al., 2001; Maas and Gommans, 2009a). ADAR 3 contains an 
N-terminal arginine (R)-rich region that is recognized by nuclear import proteins and 
therefore functions as an active NLS (Fig. 4A)(Maas and Gommans, 2009a). A similar 
R-rich region is present in a rare splice variant of ADAR2 (Maas and Gommans, 2009a, 
b). These R-rich regions bind the nuclear import proteins the importins (Maas and 
Gommans, 2009a). 
ADAR1 has an atypical NLS formed by extended regions on either side of its 
third dsRBM, with the dsRBM acting as a scaffold (Barraud et al., 2014). Conformational 
changes bring the N- and C-terminal fragments of the dsRBM into proximity to form the 
NLS, which is recognized and bound by the import protein transportin-1. The dsRBM 
serves as a linking region for the two regions to come together but is not involved in the 
interaction with transportin-1. However, binding of dsRNA to the dsRBM precludes 
binding to transportin-1 and vice versa (Barraud et al., 2014). Protein modeling of the 
NLS-dsRBM structure predicts that steric hindrance will prohibit simultaneous binding of 
dsRNA and transportin and suggests the cytoplasmic retention of dsRNA bound-ADAR1 
(Barraud et al., 2014). Earlier mutational analyses of ADAR1 dsRBMs showed that 
disrupting the ability of the dsRBMs to bind RNA increases nuclear accumulation, an 
observation that supports the paradigm of transportin-1 binding in lieu of dsRNA 
(Eckmann et al., 2001; Strehblow et al., 2002).  
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Additionally, full-length ADAR1 has an N-terminal NES that directs it to the 
cytoplasm by interaction with a nuclear import receptor, CRM1 (Poulsen et al., 2001; 
Strehblow et al., 2002). ADAR2 lacks a defined NES and is located exclusively in the 
nucleus (Desterro et al., 2003). The shorter isoform of ADAR1, p110, also lacks an NES 
due to its truncated N-terminal region and is therefore found predominately in the 
nucleus (Desterro et al., 2003; Strehblow et al., 2002). However, its dsRBMs form an 
interaction with exportin-5, an export factor that transports dsRBM proteins from the 
nucleus to the cytoplasm (Brownawell and Macara, 2002; Fritz et al., 2009). Because of 
this interaction, p110 can also act as a shuttling protein; interestingly, evidence 
suggests cytoplasmic localization of p110 in the absence of transcription, perhaps 
because its dsRBMs are free to interact with exportin-5 (Fritz et al., 2009; Strehblow et 
al., 2002).  
In the nucleus, ADAR1 and ADAR2 associate with ribosomal RNA in nucleoli and 
shuttle to the nucleoplasm during the active transcription of editing targets (Desterro et 
al., 2003; Sansam et al., 2003). Nuclear localization of ADARs is essential to site-
specific editing of mRNA because, as discussed earlier, the required duplex structure 
harboring these editing sites is generally formed by exonic/intronic complementarity and 
therefore necessitates that editing occur before splicing (Bratt and Ohman, 2003).  
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A-to-I Editing Targets 
 
Portions of the following text were previously published in Current Topics in 
Microbiology and Immunology in July 2011 (Hood and Emeson, 2012). 
 
The majority of known A-to-I editing events that alter the amino-acid sequence of 
a protein are found in mRNAs encoding neurotransmitter receptors of the central 
nervous system. These editing events and the resulting functional consequences have 
been well characterized and several are described in detail below (Table 1). 
 
Glutamate-gated ion channels 
AMPA receptors 
Ionotropic glutamate receptors (iGluRs) are involved in fast synaptic neurotransmission 
and in the establishment and maintenance of synaptic plasticity critical to learning and 
memory. Three subtypes of iGluRs, named according to selective agonists for each 
receptor subtype, include N-methyl-D-aspartate (NMDA) receptors, α-amino-3-hydroxy-
5-methyl-isoxazole-4-propionate (AMPA) receptors and kainate receptors (Ozawa et al., 
1998). Ionotropic glutamate receptors are tetrameric and their subunits share a similar 
core structure: three transmembrane segments (M1, M3 and M4), a pore loop (M2), a 
large extracellular N-terminal domain, and a highly-regulated, variably-sized C-terminal 
domain (Fig. 5). The N-terminus and a long hydrophilic region positively-charged 
arginine residue for a neutrally-charged glutamine residue at the apex of the membrane 
reentrant pore loop (M2) changes the conductance properties of channels containing an  
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Table 1. Functional consequences of editing. A summary of known editing substrates 
and the corresponding editing-mediated amino acid changes for each is shown. The 
associated functional consequences of each amino-acid change are also presented . 
(Reprinted from (Hood and Emeson, 2012) with permission). 
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edited GluR-2(R) subunit (Verdoorn et al., 1991). Heteromeric AMPA channels that 
contain the edited GluR-2(R) subunit are relatively impermeant to Ca2+ ions and show a 
linear current–voltage (I–V) relationship, whereas channels that lack or contain a non- 
edited GluR-2 (Q) subunit show a double-rectifying I–V relationship and an increased 
Ca2+ conductance (Dingledine et al., 1992; Hollmann et al., 1991; Sommer et al., 1991; 
Verdoorn et al., 1991). Quantitative PCR analyses of adult rat, mouse and human brain 
RNA have demonstrated that virtually all GluR-2 transcripts encode this critical arginine 
residue within M2 while GluR-1, -3 and -4 transcripts encode only a glutamine at the 
analogous position (Higuchi et al., 2000; Sommer et al., 1991). 
RNA editing is also responsible for an A-to-I modification in exon 13 of RNAs 
encoding the GluR-2, -3 and -4 AMPA receptor subunits to alter a genomically-encoded 
arginine (AGA) to a glycine (IGA) codon at position 764 (R/G site) to modulate the rate 
of recovery from receptor desensitization (Fig. 5). Because of faster recovery and a 
tendency for slower desensitization rates, heteromeric AMPA channels containing 
edited (glycine-containing) subunits show larger steady-state currents than the non-edit-
ed forms (Lomeli et al., 1994). Immediately following this edited codon, an alternative 
splicing event incorporates one of two mutually-exclusive exons referred to as ‘flip’ and 
‘flop’ that encode a portion of the ligand-binding domain (Fig. 5) (Sommer et al., 1990). 
Combinations of editing and splicing generate a variety of channels with unique kinetic 
properties (Koike et al., 2000; Krampfl et al., 2002; Lomeli et al., 1994). Editing at the 
Q/R and R/G sites together, play a role in receptor trafficking, as editing of the Q/R site 
attenuates formation of GluR-2 homo-tetramers and leads to retention of the GluR-2(R) 
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(Fig. 1) (Sommer et al. 1990). Combinations of editing and splicing generate a variety
of channels with unique kinetic properties (Koike et al. 2000; Krampfl et al. 2002;
Lomeli et al. 1994). Editing at the Q/R and R/G sites together, play a role in receptor
trafficking, as editing of the Q/R site attenuates formation of GluR-2 homo-tetramers
and leads to retention of the GluR-2(R) subunit in the endoplasmic reticulum (ER)
(Greger et al. 2002, 2003, 2007). Indeed, non-edited GluR-2(Q) is released to form
homomeric channels on the cell surface while edited subunits remain unassembled in
the ER (Greger et al. 2003). Interestingly, several studies have shown that editing at
the R/G site (Greger et al. 2006) and flip/flop alternative splicing (Coleman et al.
2006) also play roles in AMPA receptor trafficking.
To determine the biologic significance of Q/R site editing, mutant mice were
engineered to solely express the non-edited form of the GluR-2 transcript by
Fig. 1 Summary of the RNA editing events in mouse transcripts encoding ionotropic glutamate
receptor subunits. A schematic representation of the proposed topology for GluR subunits is
presented, based upon the topology determined for GluR-1 (Hollmann et al. 1991), indicating the
relative positions of editing sites. The genomic, mRNA and amino acid sequences surrounding
the edited regions are shown and modified nucleosides are presented in inverse lettering
68 J. L. Hood and R. B. Emeson
i ure 5. Summary of the RNA diting events in mous  transcripts encoding 
ionotropic glutamate receptor subunits. A schematic re resentation of the 
proposed topology for GluR subunits is presented, based upon the topology 
determined for GluR-1 (Hollman, 1994), indicating the relative positions of editing 
sites. The genomic, mRNA and amino acid sequences surrounding the edited 
regions are shown and modified nucleosides are presented in inverse lettering. 
(Reprinted from (Hood and Emeson, 2012) with permission.) 
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subunit in the endoplasmic reticulum (ER) (Greger et al., 2003; Greger et al., 2002; 
Greger et al., 2007). Indeed, non-edited GluR-2(Q) is released to form homomeric 
channels on the cell surface while edited subunits remain unassembled in the ER 
(Greger et al., 2003). Interestingly, several studies have shown that editing at the R/G 
site  (Greger et al., 2006) and flip/flop alternative splicing (Coleman et al., 2006) also 
play roles in AMPA receptor trafficking. 
To determine the biological significance of Q/R site editing, mutant mice were 
engineered to solely express the non-edited form of the GluR-2 transcript by Cre-
mediated deletion of the editing complementary sequence (ECS), an intronic region 
required for formation of the RNA duplex that is essential for A-to-I conversion. A 
dominant-lethal phenotype was revealed as heterozygous mutant animals appeared 
healthy until postnatal day 14 (P14), when they begin to develop seizures that lead to 
death by P20. This phenotype resulted from dramatically increased AMPA receptor 
permeability to Ca2+, concomitant with neuronal degeneration (Brusa et al., 1995). In 
subsequent studies, mice homozygous for a null allele of ADAR2 were shown to die of 
seizures before P20, a phenotype nearly identical to that seen in mice deficient in GluR-
2 editing (Q/R site). This early postnatal lethality was rescued by a targeted mutation in 
which the wild-type GluR-2 allele was modified to express transcripts with a genomically 
encoded arginine [GluR-2(R)], thereby circumventing the requirement for editing 
(Higuchi et al., 2000). Together, these studies highlight the physiological importance of 
GluR-2 editing (Q/R site) in normal brain function. However, it also should be noted that 
Ca2+-permeable AMPA receptors have been identified following mechanical or ischemic 
brain injury (Rump et al., 1996; Spaethling et al., 2008) or in specific brain regions such 
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as cerebellar Bergmann glia {Burnashev, 1992 #1029;Iino, 2001 #1065}, yet this Ca2+ 
permeability is thought to result largely from an absence of GluR-2 subunit incorporation 
into functional AMPA channels rather than the absence of GluR-2 editing.  
The editing of GluR-2 mRNA has been implicated recently in the etiology of 
sporadic amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder 
involving primarily motor neurons of the cerebral cortex, brain stem and spinal cord, 
eventually leading to death from respiratory failure (Naganska and Matyja, 2011). The 
editing of GluR-2 transcripts (Q/R site) in spinal motor neurons of ALS patients appears 
to be inefficient compared to control patients or unaffected neurons (Hideyama et al., 
2010), suggesting that the inclusion of the GluR-2(Q) subunit into heteromeric AMPA 
channels results in a Ca2+-mediated excitotoxicity that contributes to cell death 
(Kawahara et al., 2004; Kawahara et al., 2003; Kawahara et al., 2006; Takuma et al., 
1999). Support for this hypothesis was recently demonstrated in a mutant mouse line 
where ADAR2 expression was specifically ablated in ~50% of motor neurons using a 
conditional ADAR2-null allele in combination with Cre recombinase under the control of 
the vesicular acetylcholine transporter promoter. Motor neurons lacking ADAR2, 
expressing only non-edited GluR2(Q) subunits, were subject to a slow death, but could 
be rescued by expression of the Glur-2(R) allele (Hideyama et al., 2010), thus providing 
the first example of a human neurodegenerative disorder resulting from editing defects and 
further emphasizing the importance of GluR-2 editing in normal CNS function. 
Kainate receptors 
Kainate (KA) receptors, like AMPA receptors, mediate fast excitatory 
neurotransmission and are widely expressed in a number of brain regions including the 
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neocortex, the caudate/putamen, the CA3 region of the hippocampus, the reticular 
thalamus and the cerebellar granular layer (Seeburg, 1993). There are five KA subunits 
encoded by distinct genes: GluR-5, GluR-6, GluR-7, KA-1 and KA-2. GluR-5 and GluR-
6 form homomeric channels with a high affinity for kainate, but are not activated by 
AMPA (Bettler et al., 1990; Egebjerg et al., 1991). These two subunits are distinct from 
the other KA receptor subunits as their RNAs are modified by A-to-I editing (Sommer et 
al., 1991). Like GluR-2, RNAs for GluR-5 and GluR-6 have a Q/R editing site in a region 
encoding the hydrophobic pore domain (M2) which can alter the calcium permeability of 
heteromeric KA receptors containing a GluR-6 subunit (Fig. 5) (Egebjerg and 
Heinemann, 1993). There are two additional editing sites in the M1 region of GluR-6 
and editing leads to the substitution of a valine (ITT) for a genomically-specified 
isoleucine (ATT) codon (I/V site) and the substitution of a cysteine (TIC) for a tyrosine 
(TAC) codon (Y/C site)(Fig. 5). These editing events provide the possibility of eight 
different edited variants of GluR-6 subunits, all of which are expressed to a varying 
extent in the CNS, although fully edited GluR-6 transcripts represent the most 
abundantly expressed isoform in the adult nervous system (Kohler et al., 1993; Ruano 
et al., 1995). 
Electrophysiological studies have revealed that channels with editing events in 
the M1 region of GluR-6 exhibit increased calcium permeability when the M2 pore 
encodes an arginine at the Q/R site, in direct contrast to the decreased calcium 
permeability shown for R-containing GluR-2 channels (Kohler et al., 1993). When the 
M1 region of GluR-6 is not edited, encoding an isoleucine and tyrosine at the I/V and 
Y/C sites, respectively, the presence of an arginine in M2 does little to alter calcium 
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permeability (Kohler et al., 1993). Recombinant homomeric receptors composed of 
unedited kainate receptor subunits [GluR-5(Q) and GluR-6(Q)] demonstrate additional 
functional differences from those containing edited receptor isoforms [GluR-5(R) and 
GluR-6(R)], including a linear I-V relationship rather than double-rectifying properties, a 
single low conductance state rather than multiple conductance states and a highly 
significant increase in the permeability of Cl- ions (Chittajallu et al., 1999). The 
physiological relevance of these functional alterations has yet to be identified however, 
as studies of mutant mice capable of expressing only the edited GluR-5(R) isoform had 
no obvious developmental abnormalities or deficits in a number of behavioral paradigms 
(Sailer et al., 1999). While mutant mice solely expressing the non-edited GluR-6(Q) 
subunit appeared normal, they exhibited increased NMDA receptor-independent long-
term potentiation in hippocampal slices and increased susceptibility to kainate-induced 
seizures, suggesting a role for GluR-6 (Q/R site) editing the modulation of synaptic 
plasticity and seizure vulnerability (Vissel et al., 2001). 
 
The serotonin 2C receptor (5HT2CR) 
Serotonin (5-hydroxytryptamine; 5HT) is a monoaminergic neurotransmitter that 
modulates numerous sensory and motor processes as well as a wide variety of 
behaviors including sleep, appetite, pain perception, locomotion, thermoregulation, 
hallucinations, and sexual behavior (Werry et al., 2008a). The multiple actions of 5HT 
are mediated by specific interaction with multiple receptor subtypes. Pharmacological, 
physiologic and molecular cloning studies have provided evidence for fifteen distinct 
5HT receptor subtypes which have been subdivided into seven families (5HT1-5HT7) 
 28 
based on relative ligand binding affinities, genomic structure, amino acid sequence 
similarities and coupling to specific signal transduction pathways (Barnes and Sharp, 
1999; Bockaert et al., 2006; Hoyer et al., 1994; Hoyer et al., 2002). The 5HT2 family of 
receptors includes three receptor subtypes: 5HT2A, 5HT2B and 5HT2C, which belong 
to the G-protein-coupled receptor (GPCR) superfamily. The G-protein 5HT2CR interac-
tions occur in highly conserved regions of the second and third intracellular loops to po-
tentiate subsequent signal transduction pathways via Gαq/11, Gα12/13 and Gαi to modu-
late effector molecules such as phospholipases C, D and A2, as well as the extracellular 
signal-regulated kinases 1 and 2 (Berg et al., 1994; Berg et al., 1998; Werry et al., 2005; 
Werry et al., 2008a). 5HT2CR mRNA expression has been shown to be widely 
distributed in neocortical areas, hippocampus, nucleus accumbens, amygdala, choroid 
plexus, dorsal striatum and substantia nigra (Pasqualetti et al., 1999; Pompeiano et al., 
1994), suggestive of physiologic roles in reward behavior, locomotion, energy balance, 
and also when dysregulated, in the development of certain disease states such as 
obesity, epilepsy, anxiety, sleep disorders and motor dysfunction (Giorgetti and Tecott, 
2004). Many of these anatomical predictions for 5HT2CR function have been supported 
by analyses of 5HT2CR-null mice that exhibit adult-onset obesity, seizures and 
decreased cocaine-mediated locomotor activity and reward behavior (Abdallah et al., 
2009; Brennan et al., 1997; Giorgetti and Tecott, 2004; Rocha et al., 2002; Tecott et al., 
1995). 
RNA transcripts encoding the 5HT2CR undergo up to five A-to-I editing events 
that predict alterations in the identity of three amino acids within the second intracellular 
loop of the receptor to generate as many as 24 receptor isoforms from 32 edited mRNA 
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species (Fig. 6) (Burns et al., 1997; Wang et al., 2000). Sequence analysis of cDNAs 
isolated from dissected rat, mouse and human brains predicted the region-specific 
expression of 7 major 5HT2CR isoforms encoded by eleven distinct mRNA (Abbas et 
al., 2010; Burns et al., 1997; Morabito et al., 2010b; Niswender et al., 1999), suggesting 
that differentially edited 5HT2CR may serve distinct biological functions in those regions 
in which they are expressed. Sequencing studies have further revealed that edited 
mRNAs encoding isoforms with valine, serine and valine (VSV) or valine, asparagine 
and valine (VNV) at amino acids 157, 159 and 161 are the most highly expressed in a 
majority of dissected brain regions isolated from human and rat/mouse brains, 
respectively (Burns et al., 1997; Fitzgerald et al., 1999), whereas the major 5HT2CR 
transcripts in the choroid plexus encode the less edited (INV) and non-edited (INI) 
receptor isoforms (Burns et al., 1997; Morabito et al., 2010a). Functional comparisons in 
heterologous expression systems, between the non-edited (INI) and the fully-edited 
(VGV) 5HT2CR  isoforms revealed a 40-fold decrease in serotonergic potency to stimu-
late phosphoinositide hydrolysis for the VGV isoform due to reduced Gq/11-protein coup-
ling efficiency and decreased coupling to other signaling pathways (Burns et al., 1997; 
Niswender et al., 1999; Price et al., 2001). In addition, cells expressing more highly 
edited 5HT2CR (e.g. VSV and VGV) demonstrate considerably reduced (or absent) 
constitutive activation in the absence of ligand compared to cells expressing the non-
edited isoform (Niswender et al., 1999). This reduction in coupling efficiency and constit-
utive activity derives from a difference in the ability of edited 5HT2CR isoforms to spon-
taneously isomerize to the active R* conformation, a form of the receptor that interacts  
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signaling pathways (Burns et al. 1997; Niswender et al. 1999; Price et al. 2001).
In addition, cells expressing more highly edited 5HT2C receptors (e.g. VSV and
VGV) demonstrate considerably reduced (or absent) constitutive activation in the
absence of ligand compared to cells expressing the non-edited isoform (Niswender
et al. 1999). This reduction in coupling efficiency and constitutive activity derives
from a difference in the ability of edited 5HT2C isoforms to spontaneously
isomerize to the active R* conformation, a form of the receptor that interacts
efficiently with G-proteins in the absence of agonist (Burns et al. 1997; Niswender
et al. 1999). As a consequence, the observed potency of agonists with increased
affinity for the R* state is disproportionately reduced (Werry et al. 2008) and the
‘functional selectivity’ of receptor stimulus may be lost (Berg et al. 2001). More
recent studies have indicated that alterations in 5HT2C editing are observed in
suicide victims with a history of major depression (Berg et al. 2001; Gurevich
et al. 2002b; Iwamoto and Kato 2003), and in response to anti-depressant and anti-
psychotic treatment (Englander et al. 2005; Gurevich et al. 2002b), suggesting that
editing of 5HT2C transcripts may be involved in psychiatric disorders and also
may represent a homeostatic mechanism whereby 5HT2C receptor signaling is
Fig. 2 Summary of RNA recoding events in serotonin 2C receptor RNA and protein isoforms.
Schematic representation of the predicted topology and primary amino acid sequence for the
mouse 5HT2C receptor is presented along with the positions of amino acid alterations within the
second intracellular loop resulting from RNA editing events (colored circles). Nucleotide and
predicted amino acid sequence alignments between 5HT2C genomic, mRNA and cDNA
sequences are shown; the positions of the five editing sites (A–E) are indicated and nucleotide
discrepancies and predicted alterations in amino acid sequence are shown with colors
corresponding to each codon in which they reside
72 J. L. Hood and R. B. Emeson
Figure 6. Summary of RNA recoding events in serotonin 2C receptor RNA and 
protein isoforms. Schematic representation of the predicted topology and primary 
amino acid sequence for the mouse 5HT2C receptor is presented along with the 
posi ions of amino acid alterations within the second intrac llular loop resulti g from 
RNA editing events (colored circles). Nucleotide and predicted amino acid sequence 
alignments between 5HT2CR genomic, mRNA and cDNA sequences are shown; the 
positions of the five editing sites (A-E) are indicated and nucleotide discrepancies 
and predicted alterations in amino acid sequence are shown with colors 
corresponding to each codon in which they reside. (Reprinted from (Hood and 
Emeson, 2012) with permission). 
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efficiently with G-proteins in the absence of agonist (Burns et al., 1997; Niswender et 
al., 1999). As a consequence, the observed potency of agonistswith increased affinity 
for the R* state is disproportionately reduced (Werry et al., 2008b) and the ‘functional 
selectivity’ of receptor stimulus may be lost (Berg et al., 2001). More recent studies 
have indicated that alterations in 5HT2CR editing are observed in suicide victims with a 
history of major depression (Berg et al., 2001; Gurevich et al., 2002b; Iwamoto and 
Kato, 2003), and in response to antidepressant and antipsychotic treatment (Englander 
et al., 2005; Gurevich et al., 2002a), suggesting that editing of 5HT2CR transcripts may 
be involved in psychiatric disorders and also may represent a homeostatic mechanism 
whereby 5HT2CR receptor signaling is stabilized in the face of changing synaptic 
serotonergic input (Englander et al., 2005; Gurevich et al., 2002a). 
Chronic administration of IFN-α for the treatment of hepatitis C, hairy cell 
leukemia, AIDS-related Kaposi's sarcoma, chronic myelogenous leukemia, and 
melanoma have been shown to produce depressive symptoms that adversely affect 
disease outcome because of their negative impact on a patient’s quality of life, their 
interference with treatment adherence, and the development of serious complications, 
including suicide (Ademmer et al., 2001; Valentine et al., 1998; Zdilar et al., 2000). The 
mechanism by which chronic IFN-α treatment induces depression has yet to be 
established, although serotonin-mediated effects have been implicated (Cai et al., 2005; 
Lotrich et al., 2009; Menkes and MacDonald, 2000).  
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ADAR1 and the Innate Immune Response 
 
The association of 5HT2CR editing alterations and mood disorders is intriguing 
because much is still unknown about the molecular mechanisms underlying the 
development of depression. Depression is a serious public health problem. It accounts 
for 4.4% of worldwide disability (Vos et al., 2012). In the United States, major 
depression affects as many as 17% of the population (Vos et al., 2012). Depression is is 
projected to be the number two cause of disability by 2020 (Vos et al., 2012).  
An important insight into the pathology of depression is revealed by patient data; 
those undergoing treatment with interferon-alpha (IFN-α), a key component of the 
innate immune system, frequently experience depressive and anxiolytic symptoms that 
dissipate upon ending treatment (Birerdinc et al., 2012; Hoyo-Becerra et al., 2014b; 
Huckans et al., 2014). IFN-α administration is the gold standard for treatment of 
hepatitis C patients because of its dominant role in anti-viral immunity. Unfortunately, in 
some cases as many as 50% of patients undergoing treatment develop depression 
(Baranyi et al., 2013; Cattie et al., 2014; Mahajan et al., 2014; Medeiros et al., 2014). 
Thus, the positive benefit of interferon treatment in combatting a serious liver disease is  
tempered by its ill effect on the CNS. Depression and other psychiatric symptoms are 
also associated with encephalitis, viral infections, and elevated cytokines, but very little 
is known about why mood disorders develop in association with inflammation (Anisman 
and Merali, 2003; Kuppuswamy et al., 2014; Loftis et al., 2010; Mariotto et al., 2014; 
Nolan et al., 2012; Zhang et al., 2014).  
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The brain is what is termed an ‘immune-privileged’ organ. Oxygen and nutrients 
are delivered to the brain by capillaries and arteries that are lined with specialized 
epithelium to prevent toxins, pathogens, and immune effectors from entering the brain. 
This protective interface is known as the blood brain barrier (BBB) (Banks, 2014). At 
one time, it was thought that the brain was completely isolated from the host immune 
response. Rather, it is now understood that there is a reciprocal exchange of cells and 
cytokines between blood and brain tissue mediated by special transport mechanisms 
(Banks, 2014). These exchanges can be beneficial; for instance, it was recently shown 
that IFN-α increases the integrity of the BBB to prevent virus from entering the brain 
(Daniels et al., 2014). However, as evidenced by the often-severe depressive symptoms 
developed by hepatitis C patients undergoing IFN-α treatment, immune effectors can 
also negatively affect the brain. The brain is made up of delicate neuronal tissue that is 
not easily repaired when damaged, thereby requiring that a balance be struck between 
defending against pathogens and limiting damage from the immune response.  
  The innate immune system is the first line of cellular defense against pathogens. 
In contrast to adaptive immunity, in which specialized cell types mount an extremely 
specific, targeted response to eliminate a pathogen, innate immunity is a more 
generalized cellular response aimed at disrupting pathogenic activity and protecting 
against further spread (Paul et al., 2007; Watford et al., 2003). Viral and bacterial 
infections typically stimulate robust production of IFNs, small (15-34 kDa) signaling 
molecules that are an essential part of the immune system’s immediate-early response 
to pathogenic stimuli (Maher et al., 2007; Malmgaard, 2004). IFNs mediate the 
upregulation of distinct sets of genes known as interferon-stimulated genes (ISGs)  
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(Schoggins et al., 2011). ISGs carry out a wide range of activities that fall into four broad 
categories: antiviral, antiproliferative, apoptotic, and immunomodulatory (Maher et al., 
2007). Interferons act in an autocrine and paracrine fashion, both amplifying the IFN 
response of an affected cell and ‘priming’ surrounding cells for subsequent attack (Kim 
et al., 2014; Shalek et al., 2014) Underscoring the radically changing view of the brain 
and immunity, it was only a fairly recent discovery that neurons are able to both produce 
and respond to IFN (Delhaye et al., 2006).  
IFNs are divided into three main classifications: type I, II and III. IFN-α and IFN-
beta (IFN-β) are the most prevalent and well-studied of the type I IFNs (Maher et al., 
2007; Owens et al., 2014; Zuniga et al., 2007). Type II IFN, IFN-γ, is expressed chiefly 
by T-cells and natural killer (NK) cells, in contrast with the more ubiquitous expression 
of type I IFNs, and plays an important role in modulating adaptive immunity (Maher et 
al., 2007; Pollard et al., 2013). Type III IFNs, the IFN lambdas (IFN-λ), represent a 
newer classification which are functionally similar to type I IFNs but primarily affect 
epithelial cells (Donnelly and Kotenko, 2010; Durbin et al., 2013; Lopusna et al., 2013).  
IFN-α/β are major effectors of the cellular anti-viral defense. All type I IFNs act by 
binding the IFN-α receptors IFNAR1 and IFNAR2 to initiate a signaling cascade known 
as the JAK-STAT pathway (Au-Yeung et al., 2013; Maher et al., 2007; Platanias, 2005; 
Schindler and Plumlee, 2008; Stark and Darnell, 2012). Briefly, IFNAR1/2 form a 
heterodimeric complex that associates with the Janus kinases (JAKs) Jak1 and Tyk2 
through the cytoplasmic domains of each receptor. IFN binding of IFNAR1/2 induces 
conformational changes resulting in Jak1/Tyk2 transphosphorylation and activation. The 
activated kinases phosphorylate conserved tyrosine residues within the cytoplasmic 
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tails of IFNAR1/2. These phosphorylated tyrosines form docking sites for a family of 
proteins known as signal transducers and activators of transcription (STATs). STAT1 
and STAT2 are the most prevalent of the seven known STAT proteins. In the canonical 
type I IFN signaling pathway, STAT1:STAT2 heterodimers form after individually 
docking to the IFNAR1/2 receptor complex and undergoing tyrosine phosphorylation 
and release. The phosphorylated STAT1:STAT2 heterodimer interacts with IFN 
regulatory factor 9 (IRF9) to form a complex known as ISGF3. ISGF3 translocates to the 
nucleus where it activates transcription of ISGs by interacting with promoters containing 
an IFN-a/b-stimulated response element (ISRE). This is a simplified description of 
JAK/STAT signaling as there is a great deal more complexity involved in this pathway. 
For example, variations in STAT homo/heterodimer combinations, transcription complex 
formation, and protein phosphorylation all serve to fine-tune induction of distinct sets of 
ISGs. Many ISGs play a role in modulating the adaptive immune response or activating 
other effector proteins, and some have a direct anti-viral role.  
Interestingly, the p150 isoform of ADAR1 is known to be an ISG and is directly 
involved in activities relating to the antiviral response. Evidence for an interferon-
inducible ADAR1 isoform was discovered through a screen for cDNAs regulated by 
interferon (Patterson and Samuel, 1995). As described earlier, the two major isoforms of 
ADAR1 arise from alternative-splicing of multiple exon 1 structures (Fig. 3). An 
interferon-inducible promoter containing a kinase conserved sequence (KCS)-like 
element and an IFN-a stimulated response element (ISRE) drives expression of the 
exon 1A-containing transcript (Fig. 7)(George et al., 2008; George and Samuel, 1999a). 
Both IFN-α/β and IFN-γ can stimulate p150 induction, although expression is, 
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expectedly, more robust in response to IFN-α/β (Shtrichman et al., 2002); while the IFN-
α/β signaling pathway targets genes with ISRE-containing promoters, the canonical type 
II IFN (IFN-γ) signaling pathway typically stimulates transcription through utilization of 
gamma-activated sequence (GAS) promoter elements. The 1A promoter does not 
contain a GAS element, however, there can be a substantial degree of cross-talk 
between the two pathways in addition to non-canonical signaling pathways, so it is 
unsurprising that IFN-γ can induce some degree of p150 transcription (Fink and 
Grandvaux, 2013; Pollard et al., 2013). Transcription of p150 is STAT1-independent but 
requires STAT2 (George et al., 2008). This is somewhat surprising because canonical 
signaling by type I interferon involves STAT1:STAT2 heterodimer interaction with IRF9 
in the ISGF3 complex (as described above). However, accumulating evidence suggests 
that STAT2 also acts with IRF9 and other STATs independently of STAT1 (Fink and 
Grandvaux, 2013)(Fig. 7). Possibly, p150 is induced through multiple, non-typical 
signaling pathways that might serve to regulate the level of induction. 
 ADAR1 has been demonstrated to participate in many virus-related activities. Up 
to 50% of adenosines within a perfectly duplexed dsRNA can undergo A-to-I editing, 
(Nishikura et al., 1991).  As described earlier, hyperediting was first thought to be an 
“unwinding” activity until subsequently discovered to be the result of I:U mismatches 
generated by RNA editing (Bass and Weintraub, 1988; Bass et al., 1989; Ecker et al., 
1995). Hyperediting occurs within the genomes of some viruses, and is thought to be a 
deterrent to viral infection by disrupting proper protein production. The first example of 
viral hyperediting was observed in persons with a persistent measles infection known as  
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Figure 7. Type-I IFN signaling. IFN-α/β responsiveness is mediated thru the JAK-
STAT signaling pathway. The canonical pathway involves formation of ISGF3, 
composed of STAT1:STAT2 heterodimers and IRF9. ISGF3 translocates to the 
nucleus (dashed lines) where it stimulates the transcription of ISGs with ISRE-
containing promoters. STAT-1 independent complexes, such as STAT2:IRF9, can 
also stimulate transcription at ISRE-containing promoters. p150 induction is STAT2-
dependent, but STAT1-independent. 
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subacute sclerosing panencephalitis (Cattaneo and Billeter, 1992; Cattaneo et al., 
1989). Persistent measles virus infection was found to be associated with biased 
hypermutation, occurring primarily in specific measles genes (Ecker et al., 1995; Rataul 
et al., 1992). Mutation of measles genes involved in viral budding but not replication 
may contribute to persistent infection that causes fatal disease in humans (Cattaneo et 
al., 1989; Ecker et al., 1995). Interestingly, both nuclear and cytoplasmic extracts of 
human glioblastoma and neuroblastoma cell lines were able to produce the hyperediting 
activity in vitro using a measles gene-derived dsRNA substrate, recapitulating the 
hypermutation observed in human patients (Ecker et al., 1995; Rataul et al., 1992). 
Hypermutation has also been observed in the genomes of other RNA viruses, even very 
recently (Cattaneo, 1994; van den Hoogen et al., 2014; Zahn et al., 2007).  
 While ADAR1 can disrupt viral spread by hyperediting of a viral genome, some 
viruses have evolved to harness editing as part of their life cycle. In this respect, ADAR1 
appears to act as a proviral factor. Hepatitis delta virus (HDV) RNA editing is the 
prototypical example of site-specific viral editing. Antigenome HDV RNA is edited at a 
position known as the amber/W site, so named because editing at this adenosine 
changes the amber termination codon to a tryptophan (W), allowing a switch from 
translation of a shorter protein, hepatitis delta antigen (HDAg-S), to a longer form, 
HDAg-L. HDAg-S is essential for virus replication, while HDAg-L is required for 
packaging the virus and inhibiting replication. Editing allows the two proteins to be 
expressed differentially from a single mRNA and in turn complete two crucial stages of 
the viral life cycle (Casey, 2002, 2006; Polson et al., 1998; Wong and Lazinski, 2002). 
HDV editing is enhanced by IFN treatment and induction of the p150 isoform although 
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the virus limits the maximal amount of editing (Hartwig et al., 2004). In another example, 
site-specific editing of a human immunodeficiency virus (HIV-1) viral protein enhances 
its production, and overexpression of ADAR1 seems to have an overall enhancing effect 
on the virus (Phuphuakrat et al., 2008).  
ADAR1 is also involved in modulating a number of cellular stress responses.  
One of the major effectors of the antiviral response is the double-stranded protein 
kinase R, PKR. PKR is activated by autophosphorylation after binding cellular or viral 
dsRNA, and is involved a wide range of activities related to the antiviral response 
(Dauber and Wolff, 2009; Garcia et al., 2006; Zhang et al., 2001). One important 
consequence of PKR activation is the phosphorylation of eukaryotic translation initiation 
factor 2-alpha (EIF2α)(Samuel, 1979). Phosphorylated EIF2α initiates inhibition of 
cellular translational machinery which is a key strategy in preventing viral protein 
synthesis (Joshi et al., 2013). PKR and EIF2α activation are also important for signaling 
apoptosis, a crucial tactic to stop viral replication and spread(Garcia et al., 2006). 
ADAR1 inhibits the activation of PKR in an editing-independent manner, but requiring 
both Z-DNA motifs and dsRBDs (Cachat et al., 2014; Clerzius et al., 2009; Li et al., 
2012; Okonski and Samuel, 2013; Toth et al., 2009; Wang and Samuel, 2009). The 
antagonistic nature of ADAR1 and PKR function is an important interplay in balancing 
amplification of the cellular interferon/antiviral response with returning the cell to return 
to a normal state (Pfaller et al., 2011).   
One of the hallmarks of the stress response is the formation of stress granules. 
Stress granules are foci of stalled translational complexes that are formed during 
cellular distress (Thomas et al., 2011). Activation of PKR and EIF2α is important for the 
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formation of stress granules (Thomas et al., 2011). Through the deactivation of PKR, 
ADAR1 suppresses stress granule formation induced by viral infection, and interestingly 
this activity requires catalytically-active p150 (John and Samuel, 2014b; Okonski and 
Samuel, 2013). The IFN-induction of stress granule formation in the absence of virus 
could only be demonstrated in ADAR1-deficient cells, further supporting the 
suppression of stress granule formation by ADAR1 (John and Samuel, 2014b). ADAR1 
can also colocalize with stress granules, mediated by its Z-DNA binding motifs (Ng et 
al., 2013; Weissbach and Scadden, 2012).  
During stress, cells responding to interferon are arrested in the growth phase 
(Maher et al., 2007). ADAR1 plays a role in cell cycle progression by affecting 
expression of the cyclin dependent kinase 2 (Cdk2). ADAR1 binds cdk2 mRNA, so this 
effect is likely editing-mediated (Zhang and Rabinovici, 2007). ADAR1-mediated 
upregulation of cdk2 shifts cells from the growth (G0, G1) to the synthesis (S) phase 
(Zhang and Rabinovici, 2007), an effect opposite of interferon. Interferons mediate 
inhibition of c-myc expression, a gene that promotes cell entry into the synthesis phase 
(Maher et al., 2007). Interestingly, recent evidence shows that ADAR1 binds to a special 
structure in the promoter of the c-myc gene that regulates gene expression (Kang et al., 
2014). C-myc also appears to be regulated in part by PKR (Ramana et al., 2000; Raveh 
et al., 1996), once again suggesting a balancing role of ADAR1 and PKR in moderating 
the interferon response.   
Mouse models of ADAR1 deficiency strongly support its role in moderating the 
IFN response. ADAR1 null mice die at embryonic day 11.5-12 (E11.5-E12) with 
hematopoietic defects and widespread apoptosis (Hartner et al., 2004; Wang et al., 
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2004). Conditional ablation of ADAR1 in hematopoietic cells resulted in uncontrolled 
global expression of interferons (Hartner et al., 2009; Iizasa and Nishikura, 2009). WT 
hematopoietic stem cells (HSCs) were observed to predominately express p150 
(Hartner et al., 2009). In another study, conditional deletion of p150 resulted in the same 
E11-12 lethality that was observed in ADAR1 null mice. The claim that embryonic 
lethality is due to loss of p150 has been questioned because of the lack of detectable 
p150 expression in WT embryos at E11-12, and there has not yet been definitive 
demonstration that p110 protein is not affected in these mice (Matthaei et al., 2011).  
However, it could be that p150 function is vital at an earlier time point but the resulting 
lethality is only made apparent at E11-12. Also, the expression of p150 in E11-12 
embryos has never been investigated carefully, and critical but undetected expression 
of p150 in a single cell population, (i.e., the dominant expression of p150 in HSCs) 
could be responsible for the lethality (Hartner et al., 2009). Further supporting the in vivo 
role of ADAR1 in regulating interferon signaling, a recent study demonstrated that 
conditional ablation of ADAR1 in mouse brain resulted in a global upregulation of ISGs 
(Yang et al., 2014). In humans, Aicardi-Goutieres syndrome (AGS) (an autoimmune 
disorder) is associated with increases in ISG expression; intriguingly mutations in 
ADAR1 are thought to cause AGS (Rice et al., 2012). 
  Little is known about the regulation of ADAR1 editing in vivo and whether or not 
normal editing profiles are affected by p150 induction. Further, there is a dearth of 
literature describing p150 induction in the brain in response to stimuli. In a single study, 
oral Salmonella infection resulted in strong upregulation of the 1A-containing transcript 
of ADAR1 in several peripheral organs, but minimal change was seen in the brain 
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(George et al., 2005). No other ISGs were measured, but in a related paper similar 
Salmonella infection did not affect total ADAR1 expression or induce other ISGs in the 
brain (Shtrichman et al., 2002). The most likely explanation is that the brain was 
shielded from the infection. There is some evidence for IFN mediated alterations of 
editing in vitro. Increases in the editing of ADAR1 substrates occur in response to IFN in 
glioblastoma cell lines. IFN significantly increases the editing of mRNA encoding the 
DNA-repair enzyme NEIL1 (Yeo et al., 2010) and selectively increases p150 protein 
expression, concomitant with an increase in the editing of ADAR1 sites and a decrease 
in the editing of ADAR2 sites within transcripts encoding the 2C-subtype of serotonin 
5HT2CR (Yang, Wang et al. 2004). Observed decreases in ADAR2-directed editing, 
with no change in steady-state ADAR2 expression, may represent an antagonistic 
relationship between ADAR1 and ADAR2 activity (Wang, Miyakoda et al. 2004, Yang, 
Wang et al. 2004, Cenci, Barzotti et al. 2008) resulting from their ability to form 
heterodimers (Valente and Nishikura 2007) or non-productively compete for binding to a 
single RNA target (Singh, Kesterson et al. 2007, Cenci, Barzotti et al. 2008). 
 
Reovirus 
 
  Mammalian reoviruses are nonenveloped, icosahedral, dsRNA viruses belonging 
to the family Reoviradae. Reoviruses were known as “orphan viruses” because of the 
lack of association with any known disease, although reovirus antibodies are common in 
the general population (Day, 2009; Kelen et al., 1963; Tai et al., 2005). The reovirus 
genome is contained within a double-layer capsid and consists of 10 segments of 
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dsRNA, divided into three size classes (small (S), medium (M), and large (L) based on 
the sizes of the encoded viral proteins (Yin et al., 2004). Reovirus is a well-
characterized model system for the study of neurotropism and neuroinflammation 
(Oberhaus, Smith et al. 1997, Richardson-Burns and Tyler 2004, Danthi, Holm et al. 
2013). Reovirus is categorized into three serotypes (type 1 (T1), type 2 (T2) and type 3 
(T3) based in part on antibody neutralization studies, specificity of carbohydrate binding, 
and viral tropism (Forrest and Dermody, 2003; Iskarpatyoti et al., 2012; Masters et al., 
1977; Nakashima et al., 2012; Oberhaus et al., 1997; Sarkar and Danthi, 2010; Tyler et 
al., 1995; Tyler et al., 1989). While T1 reovirus infects ependymal cells lining the 
ventricular system of the brain, T3 specifically infects neurons (Forrest and Dermody, 
2003). Type 3 (T3) reovirus is a potent inducer of type-I IFN and produces a lethal 
meningoencephalitis in newborn animals associated with the apoptotic death of infected 
neurons (Oberhaus, Smith et al. 1997, Richardson- Burns, Kominsky et al. 2002, 
Danthi, Coffey et al. 2008). All reovirus serotypes can utilize the immunoglobin 
superfamily member junctional adhesion molecule-A (JAM-A) as a receptor, which 
localizes to the tight junctions of epithelium and is employed by migrating leukocytes 
(Campbell et al., 2005; Forrest and Dermody, 2003; Luissint et al., 2014). Reoviruses 
also employ cell surface carbohydrates as coreceptors in a strain-specific manner. T3 
reoviruses are known to bind sialic acid in addition to binding JAM-A, which enhances 
infection (Chappell et al., 2000). Suprisingly, direct inoculation of the brain of JAM-A null 
mice with a strain of T3 reovirus that does not bind sialic acid (T3SA-) did not affect 
reovirus replication and no differences in neural tropism were detected; WT and JAM-A 
-/- mice both demonstrated reovirus infection of the same brain regions and cell types 
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(Antar et al., 2009). This data suggested the presence of an unknown neuron-specific 
reovirus receptor. Indeed, researchers recently identified such a receptor; the Nogo 
receptor NgR1 is a leucine-rich repeat (LRR) protein involved in axonal plasticity. 
Blocking NgR1 engagement with viral particles prevented T3 reoviral infection of cortical 
neurons, and similarly, neurons lacking NgR1 could not be infected by T3 reovirus. 
NgR1 expression in the brain also closely resembles the pattern of neurotropism 
previously observed for T3 reoviral infection (Konopka-Anstadt et al., 2014).  Only 
newborn mice are susceptible to T3 reovirus infection and lethal encephalitis. Mice at 8-
10 days of age infected with T3 reovirus no longer succumb to infection or exhibit signs 
of encephalitis, while in younger mice, T3 infection is 100% lethal (Tardieu et al., 1983). 
Interestingly, mice deficient in IFNAR (IFNAR -/-) die significantly more rapidly in 
comparison to WT mice infected with reovirus, independent of strain (Dionne et al., 
2011a; Schittone et al., 2012). In IFNAR -/- mice, both the CNS and peripheral tissues 
demonstrate increased viral titers, and in the brain T3 tropism is extended to ependymal 
and meningeal cells (Dionne et al., 2011a). These findings demonstrate a protective 
role of IFN signaling in response to reovirus, limiting both viral spread and tropism.  
  Reovirus invokes many of the hallmarks of a stress response. ISGs are 
upregulated in the CNS early in response to reovirus infection, followed by genes 
involved in apoptosis and cytokine signaling (Tyler et al., 2010). T3 reovirus activates 
the innate immune response specifically through the type-1 IFN JAK-Stat pathway, the 
same general pathway through which p150 is induced (Goody et al., 2007). However, 
while it has been demonstrated that activation of STAT1 is important in protecting 
against reoviral infection, p150 is likely induced through alternative STAT2-mediated 
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signaling, as discussed earlier (Du et al., 2007; George et al., 2008). Resident immune 
cells are also a component of the CNS response to reovirus infection, involving the 
activation and infiltration of glial cells, including microglia, the resident macrophage cell 
population of myeloid lineage (Chan, Kohsaka et al. 2007, Napoli and Neumann 2009), 
and astrocytes, key mediators of neuroinflammation and neuronal homeostasis (Frank-
Cannon, Alto et al. 2009, Fuller, Steele et al. 2010). Reovirus infection leads to CNS 
infiltration by astrocytes and microglia at sites of viral injury (Richardson-Burns and 
Tyler, 2005; Schittone et al., 2012). Apoptosis is the major mechanism through which 
T3 reoviruses are thought to mediate CNS injury (Beckham et al., 2010; Danthi et al., 
2010; Oberhaus et al., 1997; Pruijssers et al., 2013; Richardson-Burns et al., 2002; 
Richardson-Burns and Tyler, 2004). The effects of apoptosis on different parameters of 
reovirus infection appear to be tissue-specific, but in the brain greater apoptotic capacity 
enhances reovirus replication, tropism, and infectivity (Pruijssers et al., 2013; 
Richardson-Burns and Tyler, 2004). Mammalian orthoreoviruses can induce the 
formation of cellular stress granules (Qin et al., 2011; Smith et al., 2006). Stress granule 
formation is induced by reovirus in the first 2-6 hours after infection, and viral 
recruitment to stress granules appears to be dependent on viral synthesis (Qin et al., 
2009). Reovirus also disrupts stress granules at later times, seemingly in coordination 
with the translation of viral mRNAs (Qin et al., 2011).  
Because of its well-characterized neurotropism, specificity for neurons, and 
robust stimulation of the type I interferon signaling pathway, I chose to utilize reovirus 
T3 strain Dearing (T3D), the T3 prototype, as a model system to further characterize the 
expression of ADAR1 isoforms in the brain in response to viral infection and activation 
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of the interferon response. It has been demonstrated that a wide range of ISGs are 
upregulated in response to reovirus. Is p150 induced in the brain in response to reovirus 
infection? Is this response differentially regulated in different brain regions? In vitro 
studies suggest that IFN-mediated induction of p150 results in increased editing of 
ADAR1-specific editing sites, and decreased ADAR2 editing. Is editing of the 5HT2CR 
altered in response to reoviral infection? Is there a global alteration in editing profiles in 
response to reovirus infection? Do brain-region specific changes in editing correspond 
with alterations in p150 induction? These questions are important foundational queries 
in trying to assess the possible link between A-to-I editing and psychiatric illness. The 
fluid nature of editing fits well with a role in the relatively rapid onset and cessation of 
depression in response to IFN, and merits further exploration. 
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Aims 
 
1) To determine whether the interferon-inducible isoform of ADAR1, p150, is 
induced in specific brain regions following reovirus infection, and to quantitatively 
characterize any increases in expression at both the RNA and protein level. 
 
2) To analyze a set of well-characterized CNS editing substrates in response to 
reovirus infection and determine whether there are alterations in editing profiles, 
potentially as a consequence of p150 induction.  
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Chapter 2 
 
REOVIRUS-MEDIATED INDUCTION OF ADAR1 (P150) MINIMALLY ALTERS RNA 
EDITING PATTERNS IN DISCRETE BRAIN REGIONS 
 
This chapter was published under this title in the journal of Molecular and Cellular 
Neuroscience in July 2014 ((Hood et al., 2014). Reprinted with permission from 
Elsevier. 
 
Introduction 
 
 The complexity of signaling networks in the central nervous system (CNS) relies 
on the tightly-controlled regulation and continuous fine-tuning of gene expression. In 
addition to changes in cell-specific transcriptional activation, dynamic alterations in RNA 
processing events such as alternative splicing (Grabowski, 2011; Gustincich et al., 
2006; Licatalosi and Darnell, 2006) and RNA editing (Balik et al., 2013; Berg et al., 
2008; Sanjana et al., 2012; Schellekens et al., 2012; Tan et al., 2009) are required to 
achieve the precise cascade of cellular events necessary for normal neuronal function. 
The conversion of adenosine to inosine (A-to-I) by RNA editing is an essential cellular 
mechanism for diversifying the transcriptome and subsequent protein activity by 
introducing non-synonymous codon changes in mRNAs encoding proteins critical for 
nervous system activity including ligand- and voltage-gated ion channels, G-protein 
coupled receptors and components of the synaptic release machinery (Hood and 
Emeson, 2012; Hoopengardner et al., 2003; Rosenthal and Seeburg, 2012).  
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To investigate potential changes in RNA editing patterns in response to a viral 
CNS infection, I have used reovirus serotype-3 strain Dearing (T3D) infection of 
neonatal mice as an experimental model system. Here I show that neonatal mice 
infected with reovirus T3D display large increases in p150 expression in all brain 
regions examined, yet the observed increase in p150 affected few editing sites. These 
findings suggest that steady-state editing patterns for ADAR targets are not primarily 
regulated by p150 expression levels. 
Materials and Methods 
 
Reovirus-infection of neonatal mice 
 Timed-pregnant dams (C57BL/6J) were purchased from The Jackson Laboratories 
(Bar Harbor, ME). Litters were divided into mixed-gender groups and treated with either 
endotoxin-free phosphate-buffered saline (PBS) (Amresco; Solon, OH) or reovirus T3D 
in PBS (Antar et al., 2009; Furlong et al., 1988). Neonatal pups (2-3 days old) were 
innoculated by intracranial (IC) injection in the left hemisphere with 5 ml PBS or 102 
plaque-forming units (PFU) of T3D reovirus in 5 ml PBS using a 10 ml Hamilton syringe 
with a 25 gauge needle. Mice were monitored daily until 10-13 days post-infection when 
a portion of the animals were generally moribund (defined by rapid or shallow breathing, 
lethargy, or paralysis), and were euthanized (Frierson et al., 2012). Mouse body weights 
were determined prior to euthanasia. All procedures were carried out in accordance with 
an IACUC-approved protocol. For determination of viral titer, dissected brain regions 
were immersed in fresh PBS and homogenized. The viral titer for each tissue sample 
was performed by plaque assay as described previously (Tyler et al., 1985). 
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Dissection of brain regions 
Mice were euthanized by cervical dislocation under anesthesia before decapitation. 
Whole brain was removed from the skull and dissections of defined brain regions were 
performed. After removal of the brain, the olfactory bulbs were removed. Using a 
straight razor, the frontal cortex was isolated by slicing at approximately 2.3 mm anterior 
to bregma; the dorsal boundary of the frontal cortex, delineated by the rhinal fissure, 
was separated and removed from the tissue below it. The hippocampus, including CA1-
3 and the dentate gyrus, was subsequently removed by separation of the cerebral 
hemispheres, using forceps to gently roll out both the right and left hippocampal 
structures from the surrounding cortex. Finally, the entire cerebellum was removed 
based on clear physical distinction from the surrounding brain tissue. Each brain region 
was dissected, weighed and flash frozen in liquid nitrogen prior to storage at -80o C. 
RNA characterization 
 All tissues were homogenized in Trizol® reagent and RNA was isolated following the 
manufacturer’s instructions (Life Technologies; Grand Island, NY). cDNA synthesis was 
performed using a High Capacity cDNA Kit with random primers following the 
manufacturer’s instructions (Applied Biosystems; Foster City, CA). A single antisense 
riboprobe was designed to differentiate between ADAR1 transcripts encoding the p110 
and p150 protein isoforms (Fig. 3A). A 449 base-pair RT-PCR amplicon encompassing 
the exon 1B/exon 2 junction of the ADAR1B transcript was cloned into vector 
pBluescript II KS- (Agilent Technologies; Santa Clara, CA). RNA labeled with [a-32P]-
uridine 5'-triphosphate (Perkin Elmer; Boston, MA) was transcribed (specific activity = 
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2.2 x 106 cpm/mmol) with T3 or T7 RNA polymerase, and ribonuclease protection 
analyses were performed as described (Emeson et al., 1989). Products were resolved 
in a denaturing 4-6% polyacrylamide gel containing 8M urea. A cyclophilin antisense 
probe was also generated as an internal loading control as previously described 
(nucleotides +34-144, GenBank accession number M19533) (Singh et al., 2007). The 
relative expression of protected fragments was quantified using a Typhoon 9400 
phosphorimager (GE Healthcare, Piscataway, NJ) with ImageQuant TL software and 
normalized to the number of adenosine residues in each protected fragment. 
Semi-quantitative analysis of ADAR1 alternative splicing patterns was performed by 
end-point RT-PCR using primers in exons 1A (sense, 5’-
AATGGATCCGGCACTATGTCTCAAGGGTTC-3’), 1B (sense, 5’-
GCTCTAGAGAGACTACGCGTTGGGACTAGCC-3’) and 2 (antisense, 5’-
ATATCTCGAGCCGGAAGTGTGAGCAAAGCCCGT-3’) or exons 6 (sense, 5’-
ATGAATCTATGGCTCCCAA-3’) and 8 (antisense, 5’-GCTTCAATGCTCTGACCAAC-
3’) and amplified for 40 cycles. Viral RNA was detected using reovirus S1 transcript 
specific primers (sense, 5’-CCTCGCCTACGTGAAGAAGT-3’; antisense, 5’-
AGCACCCAACTGGGTAACAC-3’). Resultant amplicons were resolved on a 2% 
agarose gel and visualized by ethidium bromide fluorescence, which was quantified 
using a Syngene gel imager (Cambridge, UK) with Genetools software. 
Immunoblotting analysis 
 Samples for immunoblotting were prepared as described previously (Grade et al., 
2007). Frozen tissue samples were homogenized in TRIzol® reagent. After performing 
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steps for the isolation of nucleic acids, the remaining organic phase was dialyzed 
against 0.1% SDS for three changes of buffer at 4oC using a dialysis cassette (Thermo-
Scientific; Pittsburgh, PA). Protein from samples formed gelatinous clumps that were 
solubilized in 25 mM Tris-HCl, 4 M Urea, 0.5% SDS, pH 8.0 (Hummon et al., 2007). 
Residual insoluble material was removed by centrifugation. Protein samples were 
combined with 4X LDS NuPage sample buffer prior to being resolved by electrophoresis 
on a 4-12% Bis-Tris Midi gel (Life Technologies). Electrophoresis was followed by semi-
dry transfer to a nitrocellulose membrane (Protran; PerkinElmer; Boston, MA), which 
was blocked with Li-Cor® Odyssey® blocking buffer (Licor Biosciences; Lincoln, NE) or 
0.1% non-fat dry milk, and probed with antisera directed against ADAR1 (sc-73408; 
Santa Cruz Biotechnology; Santa Cruz, CA), ADAR2 (Exalpha Biologicals, Shirley, MA), 
ADAR3 (sc-73410; Santa Cruz Biotechnology), reovirus protein sNS (Becker et al., 
2003), and b-tubulin (sc-9104; Santa Cruz Biotechnology). Washes were performed 
with 0.1% Tween-20 in TBS at room temperature. Secondary antisera consisted of 
fluorescently labeled anti-mouse (#926-32212), anti-goat (#926-68024), anti-rabbit 
(#926-32213), and anti-guinea pig (#926-68030) immunoglobulin (Licor Biosciences; 
Lincoln, NE). Images were quantified using Li-Cor® Odyssey® software. 
High-throughput sequence analysis of editing profiles 
 RNA editing profiles for ADAR substrates were quantified using next-generation 
sequencing with a variation of the high-throughput multiplexed transcript analysis 
(HTMTA) (Morabito et al., 2010b) as schematized in Figure 7. First-strand cDNA was 
synthesized in a 10 ml reaction from 1 mg of RNA using avian myoblastosis virus 
reverse transcriptase (Promega, Madison, WI) according to the manufacturer’s 
 53 
instructions in a reaction containing 0.25 mg of each substrate-specific primer with 
either T3 (5’-ATTAACCCTCACTAAAGGGA-3’) or T7 (5’-
TAATACGACTCACTATAGGG-3’) RNA polymerase promoter extensions for the sense 
and antisense primers, respectively (Table 2). Parallel control reactions lacking reverse 
transcriptase were performed for all samples. The total reverse-transcription volume 
was included in a 46.5 ml PCR amplification reaction with Phusion DNA polymerase 
(Finnzymes, Woburn, MA) according to the manufacturer’s recommendations. All 
reactions were incubated at 98oC for 30s followed by 5 cycles of amplification (98oC for 
10s, 55oC for 30s, 72oC for 45s) before addition of 1ml of exonuclease I (New England 
Biolabs, Ipswich, MA) and incubated at 37oC for 20 minutes to remove unincorporated, 
single-stranded primers. Exonuclease I was inactivated by incubation at 80oC for 20 
minutes before addition of a universal antisense primer matching the 20 nucleotide (nt) 
T7 RNA polymerase promoter with a 34-nt adapter sequence that can anneal to the 
Illumina flowcell surface (Adapter B). One of twenty-four 6-nt barcoded universal sense 
primers (Table 3) matching the 20 nt T3 RNA polymerase promoter with a 58-nt adapter 
sequence (Adapter A) also was added to the reaction (Bentley et al., 2008), which was 
amplified for an additional 25 cycles (98oC for 15s, 56oC for 30s, 72oc for 60s). Amplified 
products for each RNA target were pooled, separated in a 2% agarose gel and purified 
from excised gel slices using the Wizard SV Gel and PCR Purification Kit (Promega, 
Madison, WI). The concentration of gel-purified fragments was measured by 
spectrophotometry (A260), and ~20 ng of each sample was pooled with up to 24 other 
products containing unique barcodes and subjected to single-end sequencing using the 
Illumina Hi-seq 2000 system (Illumina, San Diego, CA). Total sequence reads obtained 
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per RNA sample (Table 4) were culled to an appropriate data set by meeting a series of 
inclusion criteria including: 1) barcode sequences are identifiable; 2) nucleotides at the 
editing site(s) are either A or G; and 3) the sequence reads precisely match the 
reference sequence(s) (Table 5). The extent of editing at each site was calculated as 
the percentage of edited (G) reads for each substrate divided by the total number of 
reads (G + A) for each target (Table 6). 
Histochemistry.  
Phosphate-buffered saline (PBS) and reovirus T3D-injected mice were sacrificed and 
brains removed as described above. Whole brains were immersion fixed in phosphate-
buffered 4% paraformaldehyde/4% sucrose for at least 48 hours and transferred to 
PBS. Brains were sent to NeuroScience Associates (NSA) Labs (Knoxville, TN) for 
processing into a ‘brain block’ in which multiple brains are aligned and encased in a 
gelatin matrix, sliced into 30-40 mM free-floating sections, and stored in 
cryopreservative solution at -20oC. Sections were rinsed in Tris-buffered saline (TBS) to 
remove the cryopreservative and antigen retrieval was performed by immersing 
sections in L.A.B. antigen retrieval solution (Polysciences; Warrington, PA) and 
incubating at 37oC for 15 minutes. After rinsing in TBS, sections were immersed in 0.6% 
hydrogen peroxide for 15 minutes to quench endogenous peroxidases, followed by 
rinsing in TBS and blocking of endogenous biotin using an avidin/biotin blocking kit per 
manufacturer’s instructions (Vector Labs; Burlingame, CA). Tissues were permeabilized 
in TBS with 0.4% Triton X-100 for 15-30 minutes. Sections were stained using either 
antiserum to ADAR1 (goat anti-ADAR1 (C-16); Santa Cruz Biotechnology; Dallas, 
Texas), antiserum to GFAP (Invitrogen, Grand Island, NY), or biotinylated tomato lectin 
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(Vector Labs; Burlingame, CA). For ADAR1 immunostaining, sections were blocked with 
5% normal horse serum for 20 minutes before incubation in ADAR1 antiserum (1:100 in 
TBS) for 30 minutes.  Sections were rinsed in TBS and incubated with horse anti-goat 
biotinylated antibody (1:600) (Vector Labs; Burlingame, CA) for 30 minutes. GFAP 
immunehistochemistry was performed with the M.O.M. kit (Vector Labs; Burlingame, 
CA) for mouse antibodies on mouse tissue as described by the manufacturer. GFAP 
antiserum was used at a 1:200 dilution. For lectin cytochemistry, sections were blocked 
using Carbo-Free Block (Vector Labs; Burlingame, CA) per manufacturer’s instructions 
and incubated for 30 minutes with tomato lectin diluted 1:500 in TBS. For the 
incorporation of the horseradish peroxidase (HRP), all sections were incubated with 
A.B.C. reagent using the ELITE A.B.C. kit (Vector Labs, Burlingame, CA) per 
manufacturer’s instructions. The chromagen substrates diaminobenzidine (DAB) and 
ImmPact Nova Red (Vector Labs, Burlingame, CA) were used to visualize peroxidase 
activity. After incubition with DAB or Nova Red (2-3 minutes), the reaction was halted by 
rinsing in water for 5 minutes. Sections were mounted onto gelatin subbed glass slides 
(NSA labs; Knoxville, TN) in acetate buffer (pH 6) and allowed to dry overnight. Sections 
were then bonded to the slides by placing in 95% ethanol for 1 min, 95% ethanol/37% 
formalin (9:1 respectively) for 5 minutes, and rinsing in 95% ethanol. Cresyl violet 
staining was performed by rehydrating slides and incubating in 0.1% cresyl violet 
solution for 5-10 minutes at 60oC. Slides were rinsed in tap water, dehydrated through 
alcohol, cleared in xylene and mounted with DPX (Electron Microscopy Services, 
Hatfield, PA). Staining was visualized using light microscopy.  
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Results 
 
Widespread CNS infection in response to reovirus treatment 
To assess the effects of reovirus T3D infection on ADAR1 expression and potential 
changes in RNA editing profiles, neonatal mice (postnatal day 2-3) were administered 
100 PFU of virus by IC injection. T3D produces a typical pattern of neurotropism in 
which neurons are infected primarily within the cortex, thalamus, hippocampus, and 
cerebellum (Oberhaus et al., 1997). The 50% lethal dose (LD50) of T3D by IC injection is 
less than 5 PFU/mouse (Mann et al., 2002). Based on patterns of reovirus tropism and 
the expression of specific ADAR substrates, we focused our analyses on three discrete 
brain regions, the frontal cortex, hippocampus, and cerebellum. Plaque assays revealed 
the absence of virus in any brain regions from vehicle-injected mice (data not shown), 
yet high viral titers varying from 1.3 x 109-1.7 x 1011 PFU/g tissue were observed in 
tissue isolated from reovirus-infected animals, demonstrating a robust infection in each 
brain region (Fig.8A). While similar viral titers were seen in the hippocampus and 
cerebellum, the mean viral titer in the frontal cortex was ~100-fold lower (Fig. 8A), 
despite the fact that this brain region was nearest to the site of viral inoculation, 
presumably reflecting region specific differences in viral tropism (Oberhaus et al., 1997; 
Richardson-Burns and Tyler, 2004). At the time of euthanasia (postnatal day 12-13), 
virus-infected mice were were weak, showed significantly decreased body weight (Fig. 
8B), and exhibited choreiform movements and erratic behavior (Dionne et al., 2011a; 
Tardieu et al., 1983), indicative of advanced encephalitis. As an index of the severity of 
viral infection, the body weights of T3D-treated animals varied considerably (Fig. 8B), 
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Figure 8. Viral titers and body weights of mice infected with T3D reovirus. 
A) Reovirus titers in dissected brain regions (Ctx, frontal cortex; Hip, 
hippocampus; Cbl, cerebellum) were determined by plaque assay at the time of 
sacrifice. Means ± SEM (n = 12 for each brain region) were statistically compared 
by mixed models ANOVA (repeated measures) with Tukey’s adjustment; ns, not 
significant, **p<0.01, ***p<0.001. B) The body weights of control mice (no treat-
ment) or animals intracranially-injected with PBS or T3D reovirus at postnatal day 
2 (P2) were determined at the time of sacrifice (postnatal day 13). Means ± SEM 
(no treatment, n = 6; PBS, n = 14; reovirus, n = 19) were statistically compared by 
ANOVA with Dunnett’s multiple comparison test; ns, not significant, ***p<0.001. 
(Reprinted from (Hood et al., 2014) with permission) 
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perhaps reflecting the broad range of viral load that differed by up to four orders of 
magnitude in discrete brain regions from individual mice (Fig. 8A).  
 
ADAR1 alternative splicing patterns are altered in response to reovirus infection 
 Little information exists about changes in ADAR1 RNA isoform expression in the brain 
in response to inflammatory stimuli. In a study of mice infected with orally-administered 
Salmonella, steady-state level of ADAR1A RNA increased dramatically in peripheral 
organs (e.g., liver), while they increased only slightly in whole brain, with levels staying 
well below those of the constitutive ADAR1B transcript (George et al., 2005). Since 
different cascades of cytokines are elicited in response to viral or bacterial infection, the 
induction of ADAR1A transcripts may be preferentially sensitive to specific cytokine 
subtypes acting through distinct signaling pathways, as has been observed for other 
interferon-stimulated genes (ISGs) (Schoggins and Rice, 2011). To quantify potential 
changes in ADAR1 RNA isoform expression in response to reovirus infection, we 
employed ribonuclease (RNase) protection and reverse transcription-PCR (RT-PCR) 
strategies with tissue samples from dissected frontal cortex, hippocampus and 
cerebellum of T3D and PBS-injected mice. A radiolabeled, antisense riboprobe was 
generated for RNase protection studies to distinguish between ADAR1 mRNA isoforms 
containing alternatively spliced interferon-inducible (1A) and constitutively (1B) 
expressed exons (Fig. 9A). ADAR1A (p150-encoding) transcripts were expressed at a 
fraction of the level observed for ADAR1B (p110-encoding) transcripts in all brain 
regions isolated from control (PBS-treated) mice (Figs. 9B, 9C). In sharp contrast, T3D-
infected animals showed a robust increase in the steady-state level of ADAR1A mRNAs 
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with no significant change in ADAR1B transcripts. In the frontal cortex, ADAR1A 
transcripts reached a steady-state level of expression nearly equivalent to that of the 
ADAR1B mRNAs, while they increased to approximately double that of ADAR1B 
transcripts in the hippocampus and cerebellum (Figs. 9B, 9C). Comparisons between  
brain regions from T3D-infected mice revealed that the fold-increase in ADAR1A  
expression correlated with the viral titer (Fig. 8A), where the smallest (3-fold) and 
largest (9-fold) changes were observed in the cortex and cerebellum, respectively (Figs. 
9B, 9C).  
While the RNase protection strategy was effective for quantifying ADAR1 isoform 
expression in response to reovirus infection (Fig. 9), RNAs containing exon 1C or 
unspliced ADAR1 pre-mRNA also would be expected to generate a 377 nt protected 
fragment, although the level of ADAR1C RNA expression is extremely low in the brain 
(George et al., 2005). We developed a semi-quantitative RT-PCR strategy to more 
specifically assess changes in ADAR1A and ADAR1B mRNA expression using sense 
primers specific for exons 1A and 1B with a common antisense primer in exon 2. 
Results using this approach were in good agreement with the RNase protection strategy 
(Fig. 9), demonstrating a significant increase in the percentage of ADAR1A mRNA 
isolated from all brain regions in T3D-infected animals (Fig. 10). ADAR1A transcripts 
represented less than 10% of the total ADAR1 RNA in PBS-treated control animals, 
whereas mice infected with reovirus showed a 3.5- to 6-fold increase in ADAR1A levels 
(Figs. 10A, 10B). In peripheral tissues, ADAR1A transcripts represented the major 
ADAR1 RNA isoform in control mice (Figs. 10A, 10B). Infection with reovirus 
significantly increased the percentage of ADAR1A transcripts expressed in the heart.  
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Figure 9..Widespread increase in ADAR1A RNA expression in response to 
reovirus infection. A) A schematic diagram of an antisense riboprobe specific for 
the ADAR1B mRNA is shown as well as the expected sizes of ribonuclease protec-
tion products generated from 1B- and 1A-containing ADAR1 transcripts. B) Ribonu-
clease protection analysis of total ADAR1 RNA expression in dissected brain regions 
for individual mice intracranially-injected with PBS (control) or T3D reovirus. Ctx, 
frontal cortex; Hip, hippocampus; Cbl, cerebellum. The migration positions for 
protected fragments generated from ADAR1A and ADAR1B RNAs are indicated as 
well as a cyclophilin loading control. C) Quantification of ribonuclease protection an-
alysis. Band intensities for ADAR1A and ADAR1B RNA isoforms were normalized to 
the internal cyclophilin control for each dissected brain region. Means ± SEM (n ≥ 5 
animals/treatment group) were statistically compared by unpaired t-test; *p ≤ 0.05, 
***p ≤ 0.001. (Reprinted from (Hood et al., 2014) with permission) 
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However, since the liver and spleen solely expressed the ADAR1A isoform in control 
animals, no further increase in the relative ratio of this RNA isoform could be observed  
While the RNase protection strategy was effective for quantifying ADAR1 isoform 
expression in response to reovirus infection (Fig. 9), RNAs containing exon 1C or 
unspliced ADAR1 pre-mRNA also would be expected to generate a 377 nt protected 
fragment, although the level of ADAR1C RNA expression is extremely low in the brain 
(George et al., 2005). We developed a semi-quantitative RT-PCR strategy to more 
specifically assess changes in ADAR1A and ADAR1B mRNA expression using sense 
primers specific for exons 1A and 1B with a common antisense primer in exon 2. 
Results using this approach were in good agreement with the RNase protection strategy 
(Fig. 9), demonstrating a significant increase in the percentage of ADAR1A mRNA 
isolated from all brain regions in T3D-infected animals (Fig. 10). ADAR1A transcripts 
represented less than 10% of the total ADAR1 RNA in PBS-treated control animals, 
whereas mice infected with reovirus showed a 3.5- to 6-fold increase in ADAR1A levels 
(Figs. 10A, 10B). In peripheral tissues, ADAR1A transcripts represented the major 
ADAR1 RNA isoform in control mice (Figs. 10A, 10B). Infection with reovirus 
significantly increased the percentage of ADAR1A transcripts expressed in the heart. 
However, since the liver and spleen solely expressed the ADAR1A isoform in control 
animals, no further increase in the relative ratio of this RNA isoform could be observed 
in response increased the percentage of ADAR1A transcripts expressed in the heart. 
However, since the liver and spleen solely expressed the ADAR1A isoform in control 
animals, no further increase in the relative ratio of this RNA isoform could be observed 
in response to viral treatment. Despite introduction of virus by IC administration into the  
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Figure 10. Semi-quantitative analysis of ADAR1A (p150) and ADAR1B (p110) 
RNA expression in brain and peripheral tissues. A) ADAR1 expression was 
quantified by end-point RT-PCR from multiple tissues in control and reovirus-infected 
animals using primers in exons 1A, 1B and 2, and the expected migration positions of 
the PCR amplicons for each alternatively spliced ADAR1 isoform are indicated. The 
presence of reovirus-derived S1 RNA was also determined. B) Quantification of 
ADAR1 alternative splicing was assessed by ethidium bromide fluorescence of RT-
PCR amplicons. Means ± SEM (n = 4 animals/treatment group) were statistically 
compared by unpaired t-test; *p<0.05, **p ≤ 0.01, ***p ≤ 0.001. (Reprinted from 
(Hood et al., 2014) with permission) 
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brain, RT-PCR analysis demonstrated the presence of reovirus S1 mRNA in all 
examined tissues, indicating the spread of viral particles outside the CNS to infect  
peripheral organs (Fig.10) (Boehme et al., 2011; Dionne et al., 2011a; Dionne et al., 
2011b).I 
 In addition to alternative splicing events that give rise to transcripts with multiple 
exon 1 structures, ADAR1 RNA expression is further diversified by competition between 
alternative 5’-splice sites in exon 7  (Fig. 2). This RNA processing event produces two 
distinct mRNA isoforms (7a and 7b) that differ by 78 nucleotides to generate ADAR1 
proteins that contain or lack a 26-amino acid linker region between the third dsRBM and 
the catalytic domain in both human and mouse isoforms (Liu et al., 1997; Yang et al., 
2003) to affect site-selective editing efficiency of ADAR1 targets (George et al., 2005; 
Liu et al., 1999; Liu et al., 1997; Liu and Samuel, 1999). A rare ADAR1 splicing event, 
referred to as 7c, results from removal of the entire exon 7 region in mature ADAR1 
mRNAs (Yang et al., 2003). 
Previous studies have suggested that alternative splicing within exon 7 is sensitive 
to inflammatory stimuli (Yang et al., 2003). To determine whether reovirus infection 
modulates alternative splicing of ADAR1 within this region of the pre-mRNA, we used a 
semi-quantitative RT-PCR strategy to determine the relative ratio of 7a and 7b 
transcripts in dissected brain regions and peripheral tissues using specific 
oligonucleotide primers in exons 6 and 8. We found that 7a transcripts represent the 
predominant ADAR1 RNA species in control animals for all brain regions examined, 
whereas roughly equivalent levels of 7a and 7b are produced in peripheral organs (Figs. 
11A, B). Expression of the 7c RNA isoform was not detected in any samples (data not 
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shown). Reovirus infection resulted in an increase in the relative ratio of 7b to 7a in all 
brain regions, yet no changes in the relative expression of these isoforms were 
observed in infected heart, liver or spleen (Figs. 11A, B). 
 
ADAR1 (p150) protein expression is increased in response to reovirus infection 
The absence of changes in ADAR1B mRNA coupled with the observed increase 
ADAR1A mRNA in virally-infected animals (Figs. 9, 10), predicted parallel effects on the 
expression of the encoded p110 and p150 protein isoforms. To quantify steady-state  
levels of ADAR1 proteins in reovirus-infected mice, we employed a immunoblotting 
strategy using a monoclonal ADAR1 antibody directed against a shared region of both  
proteins comprising all three double-stranded RNA binding domains (Fig. 2). Tissues 
from control and reovirus-infected animals were homogenized in TRIzol® reagent for 
the simultaneous isolation of both RNA and protein, as described previously (Hummon 
et al., 2007), for subsequent ADAR1 isoform analysis. Consistent with the low level of 
ADAR1A transcripts seen in uninfected animals (Figs. 9,10), no p150 protein was 
detected in any brain region examined, although the constitutively-expressed p110 
isoform was easily identified in all samples (Fig. 12A, B). In contrast to control mice, the 
p150 isoform was clearly present in infected samples from all three brain regions where 
it represented approximately 35% of total ADAR1 protein in the hippocampus and 
cerebellum and 10% in the cortex (Figs. 12A, B). This relatively low level of p150 in the 
cortex is consistent with a lower viral titer compared to other brain regions (Fig. 8A) and 
is also reflected by the absence of detectable expression for the reovirus replication 
protein σNS (Fig. 12A), despite the fact that a more-sensitive RT-PCR strategy  
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Figure 11. Differential expression of ADAR1 exon 7 splice variants in response 
to reovirus infection. A) The expression of ADAR1 isoforms using alternative 5’-
splice sites in exon 7 was quantified by end-point RT-PCR from multiple tissues in 
control and reovirus-infected animals using primers in exons 6 and 8; the expected 
migration positions of the PCR amplicons for each alternatively spliced ADAR1 
isoform are indicated. B) The relative ratio of ADAR1 alternatively spliced isoforms 
was quantified by ethidium bromide fluores- cence of RT-PCR products. Means ± 
SEM (n = 4 animals/treatment group) were statisti- cally compared by unpaired t-test; 
*p ≤ 0.05, **p ≤ 0.01. (Reprinted from (Hood et al., 2014) with permission) 
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Figure 12. Analysis of ADAR protein expression in response to reovirus 
infection. A) Representative immunoblots of ADAR protein expression in whole cell 
lysates isolated from dissected brain regions of individual mice are shown; Ctx, 
frontal cortex; Hip, hippocampus; Cbl, cerebellum. The migration positions for ADAR1 
protein isoforms (p150 and p110), ADAR2, ADAR3 and a β-tubulin loading control 
are shown. Immunoblotting analysis for a reovirus-specific protein (σNS) is also 
shown; a non-specific band in the (σNS) blots is indicated by an asterisk. B and C) 
Quantitative analysis of alterations in ADAR1 isoform expression for control (¨) and 
reovirus-infected (n) mice. Due to the absence of detectable p150 in control animals, 
data are presented as the percentage of total ADAR1 protein expression represented 
by p150 (B) or normalized to an internal β-tubulin control (C). Means ± SEM (n = 4 
animals/treatment group) were statistically compared by unpaired t-test; *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001. (Reprinted from (Hood et al., 2014) with permission) 
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confirmed cortical infection by detection of reovirus S1 RNA transcripts (Fig.10A). While 
p150 was not detectable in control animals, the reovirus-mediated change in relative 
expression shown in Fig. 6B might reflect not only the increase in p150 but also 
changes in p110 expression. However, when normalized to an internal b-tubulin control, 
the expression of p110 was not changed in the cortex or cerebellum in response to viral 
infection, but was significantly increased in the hippocampus (Fig. 12C). While previous 
studies have indicated that the inflammatory response does not affect ADAR1B or p110 
expression (George and Samuel, 1999b; George et al., 2005), increased levels of this 
protein isoform could reflect region-specific internal translation initiation at AUG249 from 
increased ADAR1A transcripts (Figs. 9,10). Immunoblotting for other ADAR family 
members, using antisera directed against ADAR2 and ADAR3, revealed no significant 
changes in expression in the cortex or cerebellum, although a significant decrease for 
ADAR2 was observed in the hippocampus (Fig.12C). 
 
High-throughput sequencing reveals few editing changes in reovirus-infected 
tissues 
To quantify potential changes in RNA editing profiles in response to reovirus infection in 
the murine CNS, we developed a high-throughput sequencing approach to 
simultaneously analyze a wide variety of ADAR substrates in infected and control 
samples from frontal cortex, hippocampus and cerebellum based upon a strategy 
previously developed in our laboratory for multiplex analysis of editing patterns for 
5HT2CR RNAs (Morabito et al., 2010b). To minimize the number of synthetic 
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oligonucleotide primers necessary for simultaneous analysis of multiple RNA targets, 
we modified our previous approach to include two amplification steps as schematized in 
Figure 13. Target-specific primers were used for five cycles of amplification for each 
substrate and to incorporate sequences for T3 and T7 RNA polymerase promoters into 
the 5’- and 3’-ends of the RT-PCR amplicons, respectively (Table 2). Following 
exonuclease I digestion to remove unincorporated PCR primers, a second round of 
PCR amplification was performed with universal primers matching the T3 and T7 
sequences to further amplify the targets and incorporate both adapter sequences 
necessary for single-end sequencing on the Illumina platform (Bentley et al., 2008) and 
one of 24 index (barcode) sequences allowing for multiplex analysis (Table 3). The 
barcodes consisted of 6-nt sequences that allowed unambiguous identification of a 
sample with up to two sequencing errors within the barcode itself. The sequencing data 
were culled to an appropriate dataset ranging from approximately 21,000 to 1,000,000 
reads (Table 4) that met a series of inclusion criteria (see Experimental Methods) when 
compared to a reference sequence for each substrate (Table 5). The extent of editing at 
each site was calculated as the percentage of edited (G) reads for each substrate 
divided by the total number of reads (G + A) for each target (Table 6). 
 
 
 
 
 
 69 
 
  
Target-specific
primer (S)
*
T3
T75 amplification cycles
Exonuclease I
Total RNA
Illumina sequencing
Reverse transcription
(random primers)
25 amplification cycles adapter B
adapter A
6 nt bar-code
Target-specific
primer ( )AS
Figure 13. Deep sequencing strategy for multiplex quantification of editing 
profiles. A schematic diagram is presented for RT-PCR amplification of a region of 
an mRNA target flanking an A-to-I editing site (Ù). In general, target-specific primers 
in adjacent exons containing either T3 (blue) or T7 (red) RNA polymerase promoter 
extensions for the sense and antisense primers, respectively (Table 2) were used for 
PCR amplification (5 cycles) before digestion of the remaining single-stranded 
primers using Exonuclease I. A second round of amplification (25 cycles) was 
performed with universal primers in which the oligonucleotide contained sequences 
matching the T3 promoter, one of 24 unique 6-nt barcode sequences (yellow) for 
sample identification, as well as an adapter sequence (Adapter A; green) or se-
quences matching the T7 and an adapter sequence (Adapter B; purple) for high-
throughput single-end sequencing on the Illumina platform. (Reprinted from (Hood et 
al., 2014) with permission) 
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For each brain region, we quantified editing for 12 transcripts, many of which encode 
proteins that are important for nervous system function (Hood and Emeson, 2012; Rula 
and Emeson, 2007). The percentage of site-selective editing for each substrate in 
control and reovirus-infected animals is summarized in Table 6. Surprisingly, high-
throughput sequencing revealed few significant changes in editing between RNAs 
isolated from PBS- and reovirus-treated animals. The extent of inter-animal variability 
was quite low due to the large number of sequence reads for each ADAR substrate. 
Small, but significant, reovirus-dependent alterations in editing for cytoplasmic FMR1 
interacting protein 2 (Cyfip2) and filamin A (Flna) in the hippocampus and bladder 
cancer-associated protein (Blcap) in the cortex were observed. While no significant 
changes in editing were observed at any of the five sites within 5HT2CR transcripts 
(Table 6), combinatorial editing at these five positions can generate up to 32 mRNA 
isoforms encoding 24 different receptor proteins (Burns et al., 1997; Niswender et al., 
1998). To further assess reovirus-mediated changes in 5HT editing profiles, we 
examined the relative abundance of each of the 32 predicted mRNA isoforms isolated 
from control and T3D-infected animals (Fig. 14). The pattern of editing for 5HT2CR 
transcripts in control animals was similar to that previously described using high-
throughput sequencing strategies where the major RNA isoform in the mouse encoded 
valine, asparagine, and valine (VNV) at amino acid positions 156, 158 and 160 of the 
receptor protein (Abbas et al., 2010; Morabito et al., 2010b). While there were 
significant changes in a limited subset of mRNA isoforms, the absolute magnitude of the 
changes was modest and the mRNA isoform distribution was largely maintained despite 
widespread reovirus infection throughout all three brain regions. 
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Figure 14. Analysis of brain region-specific 5HT2CR RNA editing profiles in 
response to reovirus infection. Editing profiles in dissected brain regions were 
determined by high-throughput sequence analysis (see Table 6). The 32 possible 
5HT2CR RNA isoforms resulting from RNA editing are represented as the 
percentage of total 5HT2CR sequence reads (see Table 4) for control (£) or 
reovirus-infected (¢) animals. Means ± SEM (n=4) were statistically compared by 
unpaired t-test; *p<0.05, ***p<0.001. (Reprinted from (Hood et al., 2014) with 
permission) 
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Increased ADAR1 (p150) in infected brain regions is not coexpressed with 
infiltrating inflammatory cells 
The observation that increased ADAR1 (p150) expression does not result in significant 
changes in RNA editing profiles raises the possibility that elevated p150 levels may not 
occur in cells expressing the largely neuron-specific editing substrates quantified in our 
studies. A critical component of the CNS response to reovirus infection is innate 
immunity involving the activation and infiltration of glial cells, including microglia, the 
resident macrophage cell population of myeloid lineage (Chan et al., 2007; Napoli and 
Neumann, 2009), and astrocytes, key mediators of neuroinflammation and neuronal 
homeostasis (Frank-Cannon et al., 2009; Fuller et al., 2010). To determine whether 
reovirus-mediated increases in ADAR1A RNA and ADAR1 (p150) protein expression 
originated in infiltrating inflammatory cells, we used immunohistochemical and 
cytochemical approaches to compare the patterns of ADAR1 expression with the 
location of microglia and astrocytes in infected brain regions. ADAR1 immunoreactivity 
was detected predominantly in the Purkinje cell layer of the cerebellum in both PBS and 
reovirus-treated animals, although the number of detectable immunopositive cells and 
the intensity of labeling was significantly increased in the T3D-infected samples (Fig. 
15A, B). Microglia were selectively labeled in brain sections from control and reovirus-
treated animals using tomato lectin, a protein lectin with specific affinity for poly-N-acetyl 
lactosamine sugars that are found on the plasma membrane and in the cytoplasm of 
microglia, as well as blood vessels (Villacampa et al., 2013). Visualization of microglia 
with tomato lectin revealed few glial cells in control animals (Fig. 15C) in contrast to 
robust glial infiltration in infected tissue throughout all cerebellar layers, including the 
white matter, granule cell layer, Purkinje cell layer, and molecular layer (Fig. 15D). 
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Although there was a partial overlap between the pattern of tomato lectin staining and 
ADAR1 expression in the Purkinje layer, this is not unexpected since one of the 
principal roles of activated microglia is to phagocytize infected neurons (Schittone et al., 
2012). Astrocytes are also a critical supportive cell type for neuronal function and can 
be identified by the expression of the distinct intermediate filament, glial fibrillary acidic 
protein (GFAP). Immunohistochemical labeling for GFAP revealed a strong astrocyte 
presence in the white matter of PBS-injected animals (Fig. 15E) while astrocytes in 
reovirus-infected tissue were observed in both the white matter and infiltrating the 
granule cell layer (Fig. 15F). The absence of significant coexpression between ADAR1 
and microglia/astrocyte markers suggests that a majority of the observed increase in 
ADAR1A RNA and ADAR1 (p150) expression does not originate in these cellular 
components of innate immunity in the CNS.  
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Figure 15. Immunohistochemical analysis of ADAR1 expression in reovirus-
infected cerebella. Coronal sections of cerebellum (30 µm) from PBS and reovirus-
inoculated mice were labeled for ADAR1 expression along with microglia and 
astrocytes. A and B) ADAR1 immunoreactivity (arrow heads) in the Purkinje cell layer 
(PL) from PBS and reovirus-infected animals. C and D) Cytochemical visualization of 
microglia using biotinylated tomato lectin. E and F) Immunolocalization of astrocytes 
(arrow heads) in the cerebella of control and reovirus–infected mice using an anti-
serum directed against glial fibrillary acidic protein (GFAP). All tissue sections were 
counterstained with cresyl violet to reveal cerebellar morphology. The scale bar for all 
panels (A-F) is presented at the bottom right in panel F; white matter (WM), granule 
cell layer (GL), Purkinje cell layer (PL), molecular layer (ML). (Reprinted from (Hood 
et al., 2014) with permission). 
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Discussion 
 
Using T3D reovirus as a model system, I have demonstrated the virus-mediated 
induction of the p150 isoform of ADAR1 in the brain. Despite induction of p150 in frontal 
cortex, hippocampus, and cerebellum, analysis of a panel of known editing substrates 
demonstrated an overall lack of changes in editing profiles. 
Since the IFN-inducible ADAR1 (p150) isoform is absent from all brain regions 
examined in control animals (Fig. 12), it is unlikely that this isoform plays a major role in 
determining normal patterns of editing for many ADAR targets in the CNS. However, 
p150 may be involved in dynamic editing changes in response to inflammatory stimuli. 
To test this hypothesis, we quantified changes in the expression pattern of ADAR1 
isoforms after direct infection with reovirus T3D and found an increase in the steady-
state level of ADAR1A transcripts (Figs. 9,10) with a robust increase in p150 protein 
expression in reovirus-infected mice (Fig.12). This finding is in contrast to a previous 
study that found increased ADAR1A transcript levels in peripheral tissues in response to 
Salmonella infection, whereas only a slight increase was observed in the brain (George 
et al., 2005). This disparity could result from differences between bacterial and viral 
infection that can produce distinct cytokine cascades (Schoggins and Rice, 2011) or 
different routes of pathogen inoculation in the two studies. 
ADAR1 is implicated in the site-selective editing of numerous RNA substrates 
throughout the brain (Lehmann and Bass, 2000; Riedmann et al., 2008). If ADAR1 
expression levels represent a rate-limiting step in the regulation of editing patterns for 
specific RNA substrates, then elevated p150 expression levels observed in response to 
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reovirus infection should result in an increase in the editing of endogenous substrates. 
However, high-throughput sequence analysis of numerous ADAR targets identified few 
significant changes in editing profiles (Table 6). While this result was unexpected, 
various possibilities could explain such an experimental outcome. Such explanations 
include a lack of significant spatial overlap between the cell-specific expression pattern 
for the ADAR substrates that were examined (Table 6) and those cells in which p150 
was selectively increased, including cells of the innate immune response. However, 
coexpression analysis of ADAR1 expression in control and reovirus-infected tissues 
demonstrated little overlap between neurons expressing ADAR1 and infiltrating 
microglia or astrocytes (Fig. 15). 
While both p150 and p110 are active in the editing of ADAR targets in transfected 
cells and demonstrate similar target specificity (Liu et al., 1999; Liu and Samuel, 1999), 
limited data are available to demonstrate distinct roles for these ADAR1 isoforms in the 
editing of endogenous substrates. As p110 is the major ADAR1 isoform expressed in 
the brain under control conditions, it is likely that this isoform is responsible for the 
normal patterns of ADAR1-dependent editing seen in the nervous system. It is unclear 
what role p150 plays in the editing of endogenous RNA substrates, as it resides 
primarily in the cytoplasm at steady-state (Eckmann et al., 2001; Fritz et al., 2009; 
Patterson and Samuel, 1995; Strehblow et al., 2002), while most ADAR targets are 
modified in the nucleus prior to splicing (Bratt and Ohman, 2003; Ryman et al., 2007). 
While the subcellular localization of p150 could affect its capacity to edit pre-mRNA 
targets in the nucleus, expression levels for the ADAR enzymes generally do not 
correlate with the extent of site-selective editing. For example, RNA transcripts 
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encoding the GluR-2 subunit of the amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA)-subtype of glutamate receptor are edited (Q/R site) to near completion by 
embryonic day 15 when no specific immunoreactivity for ADAR2 could be detected 
within the forebrain (Jacobs et al., 2009). Similarly, ADAR1 and ADAR2 expression 
remained constant, both in developing rat brain and cultured cortical neurons, while the 
extent of editing for their respective sites increased markedly (Hang et al., 2008).  
Genetically-modified mice in which the expression of p150 is selectively ablated do 
not survive beyond embryonic day 11.5 (Ward et al., 2011), similar to mice lacking total 
ADAR1 expression (Wang et al., 2004), demonstrating that the p150 isoform is 
essential for viability. However, because editing levels were not assessed in these 
animals, it remains unknown what distinct function, if any, p150 serves in the editing of 
specific RNA targets. As p150 has been implicated in numerous cellular activities which 
are either editing-independent or involve unknown substrates (Cai et al., 2010; Herbert 
et al., 2002; Nie et al., 2005; Wang et al., 2006; Wang and Samuel, 2009; Zhang and 
Rabinovici, 2007), the precise functional role(s) for this ADAR1 isoform remain to be 
elucidated. 
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Chapter 3 
 
SUMMARY 
 
 
The brain is an immune-privileged organ, vulnerable to damage by exposure to 
the innate immune response but also requiring its protection (Banks, 2014). Interferon 
stimulates induction of a cascade of ISGs that perform various functions to protect 
against pathological stimuli, but these activities can also cause harm and impair normal 
functioning (Kigerl et al., 2014; Owens et al., 2014; Spatola and Du Pasquier, 2014). 
Interestingly, the p150 isoform of ADAR1 is an ISG, but also retains all of the functional 
domains necessary to act as an A-to-I RNA editing enzyme. Numerous studies have 
reported altered editing of the 5HT2CR transcript in the brains of suicide victims and 
patients with major depressive disorder, so as an aim of this thesis, I examined virus-
mediated p150 induction in the brain as a potential link between the CNS immune 
response and mood disorders (Lyddon et al., 2013; Simmons et al., 2010). I used the 
T3D-strain of reovirus as a means of generating a potent interferon response within a 
well-characterized pattern of neurotropism that included three brain regions of interest: 
the cerebellum, hippocampus, and frontal cortex. These results are, to my knowledge, 
the first to demonstrate robust, widespread induction of the p150 isoform in the brain, 
but parallel examination of the editing profiles of a select set of neuronal editing targets 
revealed an overall lack of editing alterations, including within the 5HT2CR transcript. 
The results obtained in this work suggest that either p150 induction is uncoupled from in 
vivo editing of canonical ADAR1 targets, p150 expression levels are not a primary factor 
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in determining editing levels, and/or additional factors are involved in determining 
editing levels.  
 The increases in ADAR1, specifically p150, in response to reovirus infection 
suggested the potential for a corresponding increase in ADAR1-specific editing sites. 
However, the data obtained from high-throughput multiplexed sequencing analysis 
revealed remarkably maintained editing profiles in all of the examined reovirus-infected 
brain regions. The lack of editing changes was surprising, but there are a number of 
possible explanations for this result.  
 An obvious difference between the p150 and p110 isoforms of ADAR1 is the 
cytoplasmic localization of p150 (Desterro et al., 2003). The localization of p150 is 
important in considering its function because editing of site-specific substrates, such as 
the editing candidates analyzed in this thesis, typically takes place in the nucleus 
(Desterro et al., 2003; Sansam et al., 2003). The nucleus contains the unspliced pre-
mRNAs harboring exonic/intronic duplexes necessary for deamination of most site-
specific adenosines (Maas et al., 1996). The constitutive expression and primarily 
nuclear localization of p110, in addition to the lack of p150 expression in the brain, 
suggests this isoform is normally responsible for the editing of the neuronal ADAR1 
targets that I analyzed (Desterro et al., 2003; George et al., 2005; Hood et al., 2014; Liu 
and Samuel, 1999; Sansam et al., 2003). However, despite a steady-state cytoplasmic 
distribution, p150 contains both nuclear export and import signals and acts as as a 
nucleocytoplasmic shuttling protein (Eckmann et al., 2001; Fritz et al., 2009). Also, 
tissue culture studies have shown that p150 can also edit ADAR1-specific editing 
targets just as efficiently as p110 (Eckmann et al., 2001; Liu et al., 1999). Additional cell 
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culture studies have shown robust increases in 5HT2CR and Neil-1 transcript editing in 
response to interferon treatment, supporting the hypothesis that p150 induction might 
alter CNS editing profiles (Yang et al., 2004; Yeo et al., 2010). So, while p110 may be 
primarily responsible for constitutive editing levels, it is plausible for p150 to affect them 
as well.  
 One possibility for the lack of editing alterations is that p150 induction did not 
spatially overlap with the analyzed substrates. Immunohistochemical analysis revealed 
a specific increase of p150 in Purkinje cells, suggesting that p150 might have been 
induced only in select cell types. Because a limited set of candidate genes was 
analyzed, it is uncertain if expression of these specific transcripts overlapped with p150 
expression in the Purkinje cells, or in the cells of any of the three brain regions 
analyzed.  
 Another possibility is that p150 is primarily involved in editing a separate set of 
substrates. I examined a select set of well-characterized, robustly edited neuronal 
substrates containing multiple ADAR1-specific editing sites, but p150 might 
preferentially edit as-yet unknown targets. Bioinformatics and high-throughput 
sequencing techniques continue to add to a growing number of new editing substrates 
(Li et al., 2009; Ramaswami and Li, 2014). Aside from its localization, p150 is also 
distinct from p110 in the two Z-DNA binding motifs in its extended N-terminal region. As 
discussed in the introductory chapter to this thesis, the formation of Z-DNA is 
associated with active polymerase activity. In the nucleus, p150 could be targeted 
differentially from p110 to Z-DNA, and as a consequence linked with the active 
transcription of alternative editing substrates (Herbert et al., 1995b). In the cytoplasm, 
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dsRNA in the Z-conformation might represent an entirely different set of editing 
substrates that is targeted by p150 after induction (Brown et al., 2000; Koeris et al., 
2005; Placido et al., 2007). It is interesting that all proteins known to have the Z-alpha 
protein motif are ISGs, suggesting that binding Z-DNA or Z-RNA is an important feature 
of these proteins (Athanasiadis, 2012).  
 The cytoplasmic localization of p150 also allows access to non-coding cellular 
dsRNA substrates including Alus and miRNAs, as well as to viral dsRNA. In the reovirus 
model, p150 could be primarily involved in editing reoviral dsRNA within infected 
neurons. However, the reovirus replication cycle takes place in enclosed compartments 
within the cytosol which likely limits exposure of reoviral dsRNA to p150 (Desmet et al., 
2014; Fernandez de Castro et al., 2014). In fact, reovirus infection of p150-deficient 
cells demonstrated no effect on reovirus replication (Ward et al., 2011). Cellular sources 
of dsRNA are also candidates for p150 editing. Alu duplexes are highly edited in human, 
available both in the nucleus and cytoplasm, and are increased in the cytoplasm under 
stress (Bazak et al., 2014; Berger et al., 2014; Fitzpatrick and Huang, 2012). However, 
as Alus are primate-specific they could not serve as potential substrates in a mouse 
model of p150 induction, although they may be a target of p150 in primates. miRNAs 
are another potential p150 target. miRNA editing is an increasingly prevalent area of 
research, as the widespread regulation of gene expression by miRNAs is becoming 
more apparent (Kume et al., 2014; Warnefors et al., 2014). Multiple steps are involved 
in the processing of miRNAs to their mature form, and each stage can be regulated by 
editing both in nuclear and cytoplasmic locations (Alon et al., 2012; Kawahara et al., 
2008; Kawahara et al., 2007; Yang et al., 2006).   
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Many recent studies have implicated ADAR1 in non-editing related activities. 
Increasingly, evidence supports the overarching role of p150 in down-regulating the 
interferon response (Hartner et al., 2009; Iizasa and Nishikura, 2009; Vitali and 
Scadden, 2010). Overexpression of various ADAR1 constructs suggests that this 
function is editing-independent but requires dsRNA binding (Yang et al., 2014). 
Overexpression of p110 can also suppress the interferon response, which is not 
surprising given p150 and p110 share identical dsRNA binding domains (Yang et al., 
2014). One mechanism for mediating the interferon response is the cytoplasmic 
interaction with RIG-1 by ADAR1. RIG-1 stimulates the interferon response by binding 
to 5’-triphosphates of cytoplasmic dsRNA, while ADAR1 has an opposing effect by 
competing with RIG-1 (Yang et al., 2014). Interestingly, RIG-1 has recently been shown 
to bind the 5’-diphosphates of reoviral dsRNA, and p150 may be involved in mediating 
this interplay (Goubau et al., 2014). The formation of stress granules is also mediated 
by ADAR1 and requires the Z-domain, which is specific to p150. Additionally, ADAR1 
plays a key role in deactivation of PKR and in inhibiting apoptosis. Involvement in these 
activities could preclude p150-mediated changes in editing.  
 Recent data shows that ADAR2 editing is both positively and negatively 
regulated by other proteins (Marcucci et al., 2011). Pin1 acts a positive regulator by 
correctly localizing and stabilizing ADAR2, while WWP2 negatively regulates ADAR2 
through ubiquitination and subsequent degradation. Another study utilizing combined 
yeast and mammalian screens has identified additional factors which act as enhancers 
of ADAR2 editing (Garncarz et al., 2013). The catalytically inactive ADAR3 has also 
been suggested to inhibit editing activity. Endogenous cellular co-expression of ADAR1 
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or ADAR2 and ADAR3 appears to decrease editing activity (Sergeeva et al., 2007). 
Similarly, a catalytically inactive ADAR homolog in C. Elegans can regulate editing 
levels by binding to substrates of an active ADAR homolog (Washburn et al., 2014). 
While specific regulators of ADAR1 have not yet been identified, p150-enhanced editing 
activity might be prevented by similar factors.  
Studies have shown that ADAR expression levels in vivo are uncorrelated with 
editing levels. In Drospohila it was demonstrated that certain editing sites require only 
low amounts of enzyme for robust editing, termed “high efficiency” sites, while other 
sites are “low efficiency’” and require higher levels of ADAR expression (Jepson et al., 
2011). Therefore, another possibility for the negative editing results could be that the 
degree of increased p150 expression was too low to alter editing of any of the analyzed 
substrates. In line with this, both a decrease in p110 and an increase in ADAR2 in the 
hippocampus were revealed by immunoblotting analysis (Fig. 12). Yet, editing profiles 
were also not altered in response to these changes. 
Discrete neuronal populations may have altered editing profiles in response to 
reovirus infection, but these results could be obscured by analysis of an entire brain 
region. In the cerebellum, immunohistochemical analysis showed that the most obvious 
changes in ADAR1 expression were localized to the Purkinje cell layer (Fig. 15). 
Purkinje cells represent only a small proportion of total cerebellar cells. If reovirus 
mediated-induction of p150 in the cerebellum occurs primarily in Purkinje cells, even 
dramatic changes in the editing of substrates within these cells could be obscured by 
the analysis of the entire cerebellum. This is a difficulty likely to be exacerbated in the 
brain because of its highly heterogeneous cell population. As in this study, reported 
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editing percentages in the literature typically represent either whole brain or specific 
brain regions, and not individual neuronal cell types. It should be noted that the data 
presented in this thesis is unique in concurrently representing the editing profiles of an 
entire array of neuronal editing targets in multiple brain regions. The sequencing data 
from saline-injected control mice reveals that the editing profiles are in some cases 
markedly different from brain region to brain region. Further, the analysis of 5HT2CR 
editing by individual mRNA isoforms reveals that a range of isoforms are actually 
expressed, albeit many at low levels (Hood et al., 2014). Whether or not multiple editing 
isoforms occur in individual cells or specific cell types express only single isoforms 
remains to answered. Therefore, while the overall editing profile of discrete brain 
regions is remarkably preserved despite widespread reoviral infection, it should still be 
considered that the editing profiles of individual cell populations could be altered 
significantly.  
The results presented in this thesis demonstrate that the induction of p150 in the 
CNS in response to pathological stimuli is widespread, and yet editing levels appear to 
be unaffected. As discussed above, it is becoming increasingly clear that p150 is 
important for a number of activities related to the innate immune response, and editing 
may not be a primary function of this isoform. The data I have generated here supports 
this general theme. Still, the onset of depression is well documented in response to 
treatment with interferon, and many reports of the postmortem brain samples of suicide 
victims and patients with major depression describe changes in editing. Recent reports 
even suggest editing alterations of glutamate receptor transcripts in association with 
mental disorders (Kubota-Sakashita et al., 2014; Silberberg et al., 2012). Interestingly, 
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ADAR1 is also implicated in a number of human diseases involving interferon-related 
pathologies (Crow et al., 2014; Livingston et al., 2014; Rabinovici et al., 2001; Rice et 
al., 2012; Wu et al., 2012). 
 The findings presented in this thesis suggest that p150 is expressed in the CNS 
only under pathological conditions and its subsequent function in the brain may be 
unrelated to editing. However, I believe there is a strong possibility p150 is involved in 
editing a different set of targets that directly impact the CNS innate immune response, 
and these editing events may have a corresponding impact on the development of 
mood or neuropsychiatric disorders.  
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Chapter 4 
 
FUTURE DIRECTIONS 
 
The lack of editing changes in response to reovirus-mediated p150 induction in 
the brain was an unexpected finding. In the previous chapter I discussed several 
caveats that may explain this result, but these remain to be examined experimentally. In 
addition, the specific role(s) of p150 in nervous tissue remains to be characterized. In 
contrast to the constitutively expressed p110 isoform of ADAR1, p150’s cytoplasmic 
localization and Z-binding domains imply a special function, as does its absence in the 
brain except under inflammatory conditions. Therefore, what is the function of p150 in 
the CNS after induction by viral infection or other inflammatory stimuli? Is it important for 
the editing of any unknown neuronal targets? Does p150 induction contribute to the 
generation of mood disorders, perhaps in an editing-independent fashion, or by editing 
a target(s) other than 5HT2CR?  
In order to investigate a possible link between ADAR1 and the development of 
depression, the goal of this work was to analyze editing profiles of a well-characterized 
set of neuronal editing targets after reoviral infection. While overall changes in editing 
were not observed, it is possible that significant reovirus-mediated editing changes are 
present within specific subsets of neurons, but these alterations are masked by analysis 
of an entire, heterogeneous brain region. Editing alterations within a defined neuronal 
population would be a reasonable result of limited overlap of p150 induction and 
expression of chosen editing candidate genes. Discrete neuronal populations with 
altered editing profiles might also provide the basis of an interesting model for the 
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development of depression. Future work could address this possibility by in situ 
hybridization (ISH) analysis of p150 expression to determine the identity of specific 
subsets of neurons that display reovirus-mediated p150 induction. These cell 
populations could then be isolated from reovirus-infected and saline-treated control 
brain using laser-assisted microdissection (LAM) or fluorescent-assisted cell sorting 
(FACS) techniques followed by determination of editing levels using the multiplexed 
high-throughput sequencing method presented in this thesis (Oue et al., 2012; 
Pietersen et al., 2011; Tomomura et al., 2001). (Further, RT-PCR amplification of each 
editing substrate from these cells prior to sequencing would identify any unexpressed 
targets). For example, immunohistochemical visualization of ADAR1 in reovirus-infected 
cerebellum (Fig. 15) revealed an apparent increase in ADAR1 in Purkinje cell neurons, 
while ADAR1 expression was not detected in other types of cerebellar neurons. (An ISH 
approach would provide a more sensitive and p150-specific method for identifying 
induction in specific neuronal populations). Subsequent isolation of Purkinje neurons 
from reovirus-infected cerebellum would allow determination of editing profiles in light of 
clear p150 induction within these same cells (Tomomura et al., 2001).  
It is also possible that p150 participates in editing of an entirely different set of 
editing targets from the constitutively expressed p110 isoform. The Z-DNA binding 
domains present in its N-terminus allow it to bind the Z-form of dsRNA, further 
suggesting the possibility for a unique set of targets (Koeris et al., 2005). As discussed 
previously, p150 is involved in editing a variety of viral RNA substrates. Additionally, 
ADAR1 is targeted to stress granules via its Z-DNA binding motifs, where it could edit 
translationally arrested mRNAs (Ng et al., 2013). Future studies that employed a whole-
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transcriptome approach to identification of p150 editing sites might yield valuable 
information. Reovirus-infected brain tissue could be analyzed by RNA-seq methodology 
in comparison to uninfected tissue to identify reovirus-mediated changes in editing in 
other, perhaps as yet unidentified, editing targets. This could also be attempted in 
isolated neuronal populations as discussed above, although the small amount of RNA 
obtained from this approach may prove to be a limitation, i.e. inadequate coverage for 
RNA-seq. p150 editing ability has been demonstrated in vitro using known ADAR1 
substrates, but its true physiological targets are unknown (Liu and Samuel, 1999). 
Therefore these studies would be important in determining p150-specific editing targets 
in the brain, and specifically whether these may be linked to depression.  
Recent high-throughput sequencing studies have shown that the majority of 
editing events in human tissue occurs in Alu repeat elements (Athanasiadis et al., 2004; 
Bazak et al., 2014). Editing of Alus in the 3’UTR of mRNAs can regulate gene 
expression (Baryakin et al., 2013; Fitzpatrick and Huang, 2012; Holdt et al., 2013; Wang 
and Huang, 2014). Also, a very interesting approach would be to analyze Alu editing in 
human brain tissue, using samples from control and depressed or suicidal patients. 
Experiments could also be performed in human cell lines or primary neuronal cultures, 
either infected with reovirus or treated with IFN and then analyzed for changes in Alu 
editing. Editing analysis could be coupled with gene expression analysis to correlate Alu 
editing with alterations in gene expression. Specifically, it would be particularly helpful to 
learn whether changes in Alu-editing occurred within mRNAs with depression-mediated 
gene expression changes. In a similar vein, many new research studies are focused on 
exploring editing-mediated alteration of miRNA targets and subsequent alteration of 
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gene expression (Kume et al., 2014; Luciano et al., 2004; Tomaselli et al., 2013). 
Concurrently, numerous studies are emerging which describe a role of miRNA 
dysregulation in the development of depression and other CNS disorders (Beveridge 
and Cairns, 2012; Dwivedi, 2011; Ha, 2011; Heyer and Kenny, 2014; Issler et al., 2014).  
Overall, studies aimed at investigation of ADAR1/p150 targeting of noncoding RNAs, 
specifically Alu sequences and miRNAs, under inflammatory conditions might be a 
fruitful area of research.  
While I previously detailed the reasons for selection of the reovirus model system 
for our studies, an approach of direct interferon application might produce stronger 
effects on p150 induction and editing regulation. A recent study demonstrates direct 
ventricular application of IFN that results in depression-like behaviors and alteration of 
the serotonin system (Hayley et al., 2013) Other studies also demonstrate potential 
mouse models of IFN-induced depressive behavior and upregulation of depression-
related genes, which could be useful for correlating editing changes with functional 
consequences (Hoyo-Becerra et al., 2013; Hoyo-Becerra et al., 2014a).  
Despite being an A-to-I editing enzyme, p150 may play an editing-independent 
role in CNS infection or inflammation. Genetically modified mice deficient in 
ADAR1/p150 expression demonstrate a clear role for ADAR1 in suppression of the IFN 
response (Hartner et al., 2009; Iizasa and Nishikura, 2009; Ward et al., 2011; Yang et 
al., 2014). Evidence that p150 is localized to and suppresses the formation of stress 
granules, interferes with PKR activation, and prevents apoptosis also support the role of 
p150 as a negative regulator of the interferon response (John and Samuel, 2014a; Ng 
et al., 2013; Toth et al., 2009).  Additionally, ADAR1 dysfunction/mutation is increasingly 
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implicated in CNS diseases with an IFN-related pathology (Crow et al., 2014; Livingston 
et al., 2014; Rice et al., 2012). Together, both in vivo and in vitro studies imply a strong 
protective role of p150 induction in the brain. As such, generation of conditional mouse 
models demonstrating brain-specific p150 knockout and p150 constitutive 
overexpression could be extremely useful for understanding this role more fully in a 
variety of contexts. For instance, it would be interesting to evaluate reovirus infection in 
the CNS of mice with enhanced, constitutive neuronal expression of p150. Suppression 
of the interferon response by p150 overexpression in the context of productive reoviral 
infection would, for instance, allow observation of potential amelioratory effects on 
outward displays of CNS dysfunction, typically seen with the onset of reovirus-induced 
encephalitis.  Likewise, differences in IFN-mediated depressive behavior in p150-
overexpressing mice could provide insights into future therapeutics. Mice genetically 
modified to express only catalytically-inactive p150 or p150 Z-DNA binding mutants 
would also be useful in teasing apart the different functions of this isoform. 
The role of p150 in the CNS and its potential involvement is psychiatric disorders 
is an exciting avenue of research and my hope is that the work described in this thesis 
will serve as helpful groundwork for future studies. 
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